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Abstract 
 Aboriginal communities in the northern Ontario region utilize an abundance of 
localy grown medicinal plants. However, no prior documentation or phytochemical 
studies on the northern Ontario medicinal plants existed in literature. This prompted me 
to exploit the ethnobotanical resources in this region towards the study of antibacterial 
bioactivity and aleviation of oxidative stress. Oxidative stress plays a fundamental role 
in the pathogenesis of many major human ilnesses, such as cancer, cardiovascular 
diseases, diabetes and Alzheimer’s syndrome. Also, infectious diseases are a major 
concern in our society due to the advent of multiple drug resistant strains of bacteria that 
cause milions of mortalities worldwide.  
 From the accumulated list of 48 northern Ontario medicinal plants, I selected 21 
plants based on their documented anticancer, antibacterial, antioxidant, antidiarheal and 
anti-inflammatory properties. These plants were separated into leaf, flower, stem and root 
tissues and extracted with ethanol. In total, 43 extracts were assayed for antioxidant and 
antibacterial activity in this study. The antioxidant activity was evaluated through the 
DPPH (2,2-diphenyl-1-picrylhydrazyl), ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) diammonium salt), ORAC (Oxygen radical absorption capacity), and 
EC50 (half maximal efective concentration) assays. The total phenolic content of 
medicinal plants was also determined. The antibacterial activity was determined through 
the hole-plate difusion and minimum inhibitory concentration (MIC) assays on Bacilus 
cereus, Escherichia coli, Micrococcus luteus, Mycobacterium avium subsp. avium, 
Paenibacilus alvei and Aeromonas caviae bacteria. The crude extract was fractionated 
through manual liquid chromatography (LC) into five fractions of varying polarity using 
a mixture of hexane: ethyl acetate: methanol solvents and assayed for inhibitory activity 
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in the MIC assay. Also, a few plants were shortlisted and studied for more detailed 
antibacterial activity through minimum bactericidal concentration (MBC) and time-kil 
analyses.  
 In the antioxidant assays, al plant extracts exhibit some level of activity, 
however, a few were exceptional. The extracts of Cornus canadensis, Ledum palustre, 
Prunela vulgaris, Arctostaphylos uva-ursi, and Apocynum androsaemifolium L. from the 
Cornaceae, Lamiaceae, Ericaceae and Apocynaceae families, respectively, display the 
highest antioxidant activity and total phenolic contents. In the antibacterial assays, plants 
from the Asteraceae, Apocynaceae, Cornaceae and Ericaceae families display the 
highest activity.  Particularly, the leaf and/ or flower extracts of Xanthium strumarium, 
Anaphalis margaritacea, Arctostaphylos uva-ursi, Apocynum androsaemifolium L., 
Cornus canadensis, Solidago canadensis and Grindelia squarrosa exhibit high inhibition 
diameters and low MIC values. Also, for the majority of extracts, an increase in 
bioactivity was observed in the medium polarity LC fraction, relative to the crude. 
Particularly, the medium polarity fraction of Anap. margaritacea flower exhibits MIC 
values in the range of 0.08 -1.25 mg/ml against al six bacteria tested. The crude extract 
of Anaphalis margaritacea flower also displays MBC values in the range of 0.16 - 5 
mg/ml against A. caviae, M. luteus, P. alvei and B. cereus bacterium and demonstrates 
complete extermination within eight hours of incubation. Overal, this investigation 
provides evidence for the application of these medicinal plants towards the treatment of 
infectious and oxidative stress related diseases in Native Aboriginal communities.  
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CHAPTER #1 
General Introduction: Northern Ontario Medicinal Plants 
Haider M. Hassan  
ABSTRACT 
Majority of scholarly investigations conducted in the 20th century have provided the incentive for 
establishing plants as sources of diverse phytochemicals. With infectious and oxidative stress 
related diseases causing milions of mortalities worldwide and the advent of multiple drug 
resistant strains of bacteria, the discovery of new bactericidal and anticancer agents is crucial. 
Hence, presented here is a novel list of 48 northern Ontario medicinal plants that may be a source 
of antifungal, antibacterial, anticancer and/or antioxidant phytochemicals. A total of 2 ferns and 
alies, 2 sedge and grass, 6 trees, 4 shrubs, 1 vine and 33 herbs were identified. These plants 
were accumulated through interviews with native Elders and a survey of ethnobotanical literature 
on northern Canadian species of medicinal plants. I also present a critical review of their 
potential constituents, medicinal properties, and analysis of four promising plants (Skulcaps, 
devils club, St. John’s Wort and evergreens). Skulcaps and St. John’s Wort are model plants 
with documented anticancer, antibacterial and antifungal bioactivities. However, a considerable 
gap in ethnopharmacological data was found for species of skulcaps (Scutelaria galericulata, 
parvula and lateriflora) and St. John’s Wort (Hypericum mutilum, majus, canadense) growing in 
the northern Ontario region. This finding provides promising incentives in the 
ethnopharmacological community for medicinal research in this region. 
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1. Introduction 
Global Cancer (GLOBOCAN) statistics estimated a global count of 12.7 milion new 
cancer cases and 7.6 milion cancer related mortalities to have occurred in 2008; approximately 
56% of the cases and 64% of the deaths occurred in economicaly developing countries (Jemal et 
al. 2011). According to an estimate by Ames et al. (1995), one in four deaths in America are due 
to cancer. Propagation of oxidative stress is one of the major causes of cancer, which is generated 
through an imbalance between reactive oxygen species (ROS) and antioxidant molecules. The 
chronic increase in ROS is known to amplify genetic instability, which triggers cel 
transformation and tumor progression. Also, many studies indicate that an increase in ROS 
results from stimulation of the cel cycle progression by growth factors, or mutations that activate 
the tyrosine kinase pathways (Shumacker et al. 2006). As such, the discovery of novel 
antioxidant agents from the plant and synthetic sources has received renowned atention.  
Infectious diseases are also a major problem, particularly in the developing countries. 
Worldwide, one in three deaths result from an infectious or communicable disease (Lopez 2006). 
This problem can be traced to the evolution of multiple drug resistant strains of pathogenic 
bacteria due to a concentrated use of existing antimicrobial drugs (Ahmad et al. 1998). These 
issues have created immense clinical problems in the treatment of infectious diseases. 
The agricultural industry also sufers from the advent of microbial infestations on crops 
(Hadacek & Greger 2000). Some estimates claim that plant pathogens cause an approximate 20% 
reduction in crop yield per year worldwide (Oerke et al. 1994). As such, with increasing world 
population (Gomiero et al. 2011), and limited land for agricultural growth, the use of fungicides 
and bactericides remain an integral part of agriculture and food protection. 
Introduction           Chapter 1: General Introduction 
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1.1. Natural Products as Promising Aspects 
        Medicinal properties of various plant extracts have been documented since the 5th 
century B.C. It is estimated that more than two-thirds of curent drugs are derived from plant 
sources (Coe & Anderson 1996). Between 1981-1982, 60% al drugs developed to combat 
oxidative stress originated from plant sources (Newman & Cragg 2007). In the case of infectious 
diseases, that number reached 70%. Furthermore, a scrutiny of medical indications by the source 
of compounds has demonstrated that natural products and related drugs are used to treat 87% of 
al categorized human diseases, including antibacterial, anticancer, anticoagulant, anti-parasitic, 
and immunosuppressant agents, among others (Newman et al. 2003). Between 2001 and 2005, 
23 new drugs from plant origins were introduced to treat diseases such as cancer, fungal 
infections, bacterial infections, diabetes, atopic dermatitis, Alzheimer’s syndrome, and genetic 
diseases such as tyrosinemia and gaucher’s disease (Lam 2007). Despite the tremendous success 
of drug discovery from natural sources, the pharmaceutical industry has retracted its investigation 
of plants as sources of novel chemicals (Coe & Anderson 1996; Farnsworth & Moris 1976; Lam 
2007). 
        There are major economic incentives for the discovery of natural products. Herbal 
therapy is a way of life in almost 80% of the people in rural areas, especialy those in Asia, Latin 
America and Africa (Shale et al. 1999). According to a World Health Organization (WHO) 
survey, about 70 - 80% of the total world population depends on herbal remedies as a source of 
their primary health care (Chan 2003). It is estimated that in U.S., approximately 30% of the 
population uses $13 bilion worth of alternative or herbal remedies per year (Keen et al. 1994). A 
relatively recent telephone survey by the National Population Health Survey (NPHS) of 11, 424 
Canadian adults reported a 15% usage of natural products within the prior 2 days (Singh & 
Natural Products as Promising Aspects       Chapter 1: General Introduction 
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Levine 2007). Another survey of the Canadian breast cancer patients found that 25% reported 
usage of herbal medicines (Smith & Boon 1999). The great demand for herbal products, and the 
diminishing forestry in Northern Ontario, should incentivize the pharmaceutical industry and 
research community to investigate plants in this region for sources of phytochemicals for the 
treatment of oxidative stress related and infectious disease.  
 
2. Traditional Medicinal Plants of Northern Ontario  
2.1. Northern Ontario Medicinal Plants with Potential Bioactive Substances  
 There has been considerable research in Canada on medicinal plants colected by 
Aboriginal First Nations individuals (Westfal & Glickman 2004). Jones et al. (2000) tested 18 
medicinal plants, used by First Nations peoples in eastern Canada, for their anti-fungal properties 
against opportunistic human pathogens. They discovered that 13 plants contained anti-fungal 
properties, and that medical knowledge held by First Nations Peoples significantly corelates 
with the laboratory findings. Fraser et al. (2007) assessed 36 medicinal plants from two Cree 
communities (Whapmagoostui and Mistissini) for antioxidant activity via 2,2-diphenyl-1-
picrylhydrazyl (DPPH) assay and their ability to protect human low-density lipoprotein from 
oxidation. Upon comparison of antioxidant activity of these 36 medicinal plants with 16 extracts 
not utilized for medicinal purposes, a positive correlation was found between the established 
traditional knowledge of Cree Elders and the radical scavenging activity of these plants. 
Essentialy, plants used by Native Indians towards the cure of certain ilnesses have more 
therapeutic potential than a randomly chosen sample (Arnason et al. 1981). 
Traditional Medicinal Plants of Northern Ontario     Chapter 1: General Introduction 
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       The list of northern Ontario medicinal plants (Table 1) was compiled through interviews 
with native Elders and a survey of ethnobotanical literature (Argus et al. 1999; Arnason et al. 
1981; Bryan et al. 1993; Chevalier 1996; Etkin 2008; Hälvä & Craker 1996; Heatherly 1998; Li 
2000; MacKinnon 2009; Mowrey 1990; Smal & Catling 1999; Wilard et al. 1992). The criteria 
for plant selection was based on the North American First Nations ethnobotanical medicinal plant 
trend (Jones et al. 2000), which states that plants used towards the treatment of burns, cuts, 
infections, diarhea, and mouth conditions are likely to contain antibacterial substances. Plants 
used towards the treatment of oxidative stress related diseases (i.e. cancer, inflammation) were 
also included in the list. A total of 2 fern and aly, 2 sedge and grass, 6 trees, 4 shrubs, 1 vine and 
33 herbs were accumulated with reference to their conventional medicinal names (Table 1). 
Overal, 105 diferent species of plants are listed due to the existence of various species within 
the conventional nomenclature. The potential secondary metabolite(s) of plants were identified 
via a rigorous literature analysis of their medicinal properties. No prior herbal research has been 
documented for northern Ontario; as such, this is the first reporting of medicinal plants in this 
region.  
3. Research on Medicinal Plants of Northern Ontario  
        Northern Ontario constitutes 87% of the land mass alocated for the province of 
Ontario, but houses only 6% of the provincial population. Unlike urban centers, it is renowned 
for investment in forestry and many industries resort to forestry resources for economic stability 
and diversification (Duinker et al. 1991). This region has a large diversity of plant species used in 
traditional aboriginal communities for various medicinal incentives. Described here are a few 
examples of medicinal plants from northern Ontario that have atracted considerable interest in 
the ethnobotanical community.  
Research on Medicinal Plants of Northern Ontario     Chapter 1: General Introduction 
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3.1. Skulcaps (Scutelaria sp.) 
       Scutellaria (Lamiaceae plant family) genus contains approximately 350 species (Shang 
et al. 2010). It is widely distributed in mountains of temperate and tropical regions including 
Europe, North America and South Asia. They range from 0.05 - 1 m in height and have been 
used for thousands of years in the traditional Chinese medicinal (TCM) practices (Shang et al. 
2010).  Skulcaps are copiously noted for anti-proliferative, anti-cancer, antibacterial and 
antiviral bioactivities. Scutelaria baicalensis (Huáng Qín Täng) is one of the 50 fundamental 
herbs in Chinese medicine (Yin et al. 2004) and a significant quantity of literature documents its 
anti-cancer activity (Kumagai et al. 2007; Parajuli et al. 2009; Scheck et al. 2006; Shang et al. 
2010; Ye et al. 2002). Ye et al. (2002) demonstrated that S. baicalensis is cytotoxic at half 
maximal Inhibitory Concentration (IC50) of 1.1, 0.9, 0.52, 0.82 and 1.1 mg/ml to squamous cel 
carcinoma, breast cancer, hepatocelular carcinoma, prostate carcinoma, and colon cancer, 
respectively. There was a strong dose-dependent inhibition of proliferation in al cel lines tested. 
Scheck et al. (2006) correlated its bioactivity to the presence of phenolic compounds Baicalein 
and Baicalin (1a and 1c, respectively) and concluded a possible synergistic viability when used 
in concert with other chemotherapeutic agents. Kumagal et al. (2007) associated the anti-
proliferative efect of S. baicalensis to mitochondrial damage, modulation of anti-apoptotic 
family of genes (Bcl), increased level of cyclin dependent kinase (CDK) inhibitor p27KlP1 and 
decreased level of proliferation stimulatory c-myc gene. Among other species in the genus, 
Scutelaria barabata has also been shown to exhibit strong in vitro anti-cancer activity (Cha et al. 
2004; Kumagai et al. 2007; Shang et al. 2010; Shoemaker et al. 2005; Yin et al. 2004; Yu et al. 
2007). Despite the documented success of this herb in treating cancer, research on northern 
Ontario species of Scutelaria (S. galericulata, S. parvula and S. lateriflora) is vastly lacking. 
Research on Medicinal Plants of Northern Ontario     Chapter 1: General Introduction 
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This situation presents a promising opportunity for researchers towards discovery of potential 
anticancer agents.  
       Scutelaria sp. also exhibit antimicrobial properties. Sato et al. (2000) isolated flavonoids 
from Scutelaria barbata that displayed selective toxicity towards methicilin-resistant 
Staphylococcus aureus (MRSA) and methicilin sensitive S. aureus strains (MSSA). The most 
potent component was found to be apigenin (1b) with minimum inhibitory concentration (MIC) 
of 3.9-15.6 μg/ml against MRSA and MSSA. Baicalin, an antibacterial, anticancer, anti-HIV and 
anti-inflammatory flavonoid representing 5% of the dry weight of S. baicalensis, also displayed a 
half maximal minimum inhibitory concentration (MIC50) and MIC90 of 1.04 and 1.30 mg/ml, 
respectively, against ten strains of Helicobacter pylori (Wu et al. 2008). The myriad signature 
bioactivities recorded for this herb, promotes the Scutelaria species as interesting subjects of 
ethnopharmacological research.  
3.2. St. John’s Wort (Hypericum sp.) 
 
      St. John’s Wort is a wel-studied perennial herb that grows widely in Europe, Western 
Asia, North Africa and America (Gupta & Möler 2003). It is also known as amber, Klamath 
weed, milepertuis, rosin rose, or Tipton's weed (Rowe and Baker 2009). St. John’s Wort was 
utilized in ancient native traditions for over 2000 years as a spiritual plant to aleviate sickness, 
misfortune, anxiety, depression and served as a topical treatment for superficial wounds and 
burns (Gupta & Möler 2003; Rowe and Baker 2009). Active ingredients from Hypericum 
perforatum have claimed antibacterial, antidepressant, antiviral and anticancer properties. Also, 
the anti-depressant activity of this herb is wel debated, and has been atributed to the inhibition 
of norepinephrine, serotonin and dopamine synaptosomal uptake in many double blind studies 
Research on Medicinal Plants of Northern Ontario     Chapter 1: General Introduction 
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(Carpenter 2011; Gupta & Möler 2003; Müler et al. 1997). However, Rapaport et al. (2011) 
refutes this result due to a high response measurement of the placebo dose, relative to St. John’s 
Wort extract. Atention has been alocated to hyperforin (2) and hypericin (3) as the active 
ingredient behind this property (Barnes et al. 2001). 
        Hyperforin (2), a natural phloroglucinol isolate, is also reported to have anticancer 
activity. Merhi et al. (2011) discovered that hyperforin (2) inhibited the growth of AML cel lines 
(U937, OCI-AML3, NB4, HL-60) by inducing apoptosis in a time and concentration-dependent 
manner. The normal blood cels were not afected in the treatments. This activity has been 
atributed to the suppression of Cytochrome C Oxidase-1 (COX-1) and 5-Lipoxygenase (5-LO) 
activity, key enzymes in the formation of pro-inflammatory eicosanoids (Albert et al. 2002). 
Further, hyperforin has been shown to act synergisticaly with hypericin (3) in its inhibitory 
efect on leukemic cel growth (Hostanska et al. 2003). The antibacterial property of hyperforin 
(2) has also been observed only at high concentrations, and its low potency makes it unlikely to 
be used towards this aspect.  
      Preparations of H. perforatum are available at pharmacies, herbal medicine and health-
food stores. It is considered one of the best seling herbal products. Due to the success of this 
herb, it is surprising that many species in this genus have not been wel researched (i.e. H. 
mutilum, H. majus, H. canadense). H. multilum and H. canadense are species of St. John’s Wort 
found in northern Ontario. Though antibacterial activity has been reported for the H. multilum 
extract (Carlson et al. 1948), the literature is significantly outdated and lacking in aptitude. This 
presents a promising opportunity for contemporary research.  
Research on Medicinal Plants of Northern Ontario     Chapter 1: General Introduction 
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3.3. Devils Club (Oplopanax horridus) 
Devil’s Club (Oplopanax horridus), native to Thunder Bay, is considered one of the most 
important spiritual and medicinal plants to indigenous communities within its afinity. It is a 
large shrub located in cool moist forests of western North America and is known for its large 
palmate leaves and erect, woody stems covered in britle spines.  Devil’s club is wel-researched 
for its hypoglycemic, antibacterial, and antioxidant properties. Kobaisy et al. (1997) studied the 
anti-microbial properties of polyyne (4) isolated from the root bark of Devil’s Club. The isolate 
exhibited significant anti-candida, antibacterial and antimicrobial activity, with an MIC of 
10g/ml against Mycobacterium tuberculosis and isoniazid-resistant Mycobacterium avium in a 
disc difusion assay. These results are in corelation with findings that the inner bark of Devil’s 
Club has been used by the indigenous people to cure tuberculosis (Thommasen et al. 1990). 
Devils Club is also noted for anti-proliferative, antioxidant and anti-viral activities. McCutcheon 
et al. (1995) studied anti-viral activity of inner bark methanolic extract of Devil’s Club and found 
it partialy inhibited the Herpes virus type 1. Tai et al. (2006) documented anti-proliferative 
activity of inner bark extract against K562, HL60, MCF7 and MDA-MB-468 cancer cel lines. 
The ethanolic extracts exhibited synergistic efects when combined at non-inhibitory 
concentrations with non-cytotoxic concentrations of camptothecin or paclitaxel. The anti-
proliferative activity of Devils Club extracts may be corelated to its strong antioxidant profile.  
Devils Club has been unanimously quoted in the Native community to relieve diabetic 
symptoms. Large et al. (1938) demonstrated that at extract concentrations of 0.1, 0.2, and 0.25 
c.c. per lb. of body weight, a rapid reduction in blood sugar from 35 to 70 mg. per 100 c.c. was 
observed. On the contrary, Thommasen et al. (1990) reported an absence of hypoglycemic 
activity when administered to an insulin-dependent diabetic patient, a newly diagnosed non-
Research on Medicinal Plants of Northern Ontario     Chapter 1: General Introduction 
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insulin-dependent diabetic, and two healthy individuals in a closely monitored study. With these 
apparently contradictory data, further investigations are necessary to evaluate the hypoglycemic 
property of this plant. 
Also, considering the range of bioactivities, it is surprising that very few publications 
report on the isolation and characterization of a bioactive compound from Devil’s club. More 
research needs to be geared towards this aspect. 
3.4. Evergreens 
      Evergreen plants have a long leaf lifespan, and are active in al seasons (Moore 1980). 
They encompass a wide aray of trees and shrubs, including conifers, gymnosperms and 
angiosperms. Evergreen trees, perennials and herbs have been used for the treatment of infection, 
cancer or toothache aleviation in native communities. Prior to winter, a sappy substance caled 
“pine gum” is harvested from Juniper, Jack pine, Balsam Fur, Spruce, Tamarack or other conifers 
and rubbed as a paste on wounds to prevent infection. This paste is also rubbed on teeth to 
mitigate toothaches. The root of evergreen plants is harvested in the winter, extracted with water, 
and applied on superficial wounds or cuts to prevent infection.  
      Clubmoss (Lycopodiaceae family) is a low growing, non-flowering, spore producing 
vascular plant that covers approximately 80% of the soil surface in many grassland communities 
of the northern mixed prairie of North America (Romo 2010). Clubmoss species have been used 
in Chinese medicines as tea or poultice for the treatment of amnesia, contusion, sweling, 
schizophrenia and hematuria (Bai 1993). Lycopodium varium from New Zealand exhibited 
insecticidal activity (Ainge et al. 2002). Orhan et al. (2007) tested the antibacterial activity of 
Lycopodium clavatum and found that it inhibited al the bacteria tested with an MIC range of 4-
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64 μg/ml. Their study also revealed antifungal and antiviral properties from this species. Further, 
many alkaloids displaying a wide array of bioactivities have been isolated from club mosses. 
Huperzine A (5), lycopodine (6), serratezomines, carinatumins, and complamandine are among a 
few alkaloids isolated that exhibit insecticidal, antibacterial, anti-acetylcholinesterases and 
induction of neurotropic factor secretion activity, respectively (Choo et al. 2007; Kubota et al. 
2009; Morita et al. 2005; Orhan et al. 2007). Huperzine A also exhibits anticholinesterase activity 
and is presently in phase I clinical studies for the treatment of Alzheimer’s disease in elderly 
patients (Rafi et al. 2011). It has been used for the treatment of myasthenia gravis, dementia and 
senile memory improvement (Yu et al. 1986). However, lycopodine is the major alkaloid found 
in clubmosses (Orhan et al. 2007). 
 
4. Perspectives  
There has been considerable research on the isolation of bioactive substances from 
medicinal plants, their efficacy against diseases, potential targets, architectural characterization, 
and therapeutic properties. Several plant-derived drugs have been introduced in the market, and 
there is significant evidence to support continued research on their extraction and isolation. For 
example, the famous anticancer drug Paclitaxel was isolated from pacific yew (Taxus brevifolia) 
and is now administered in the treatment of breast, lung and ovarian cancer (Jemal et al. 2011). 
Past experiences have taught us that plant phytochemicals possess a broad range of bioactivities 
against bacteria, fungi, cancer and other diseases. New procedures and advanced separation 
techniques may lead to the discovery of novel chemical entities previously neglected. Overal, 
many plant compounds remain untapped resources in medicine; as such, it is essential to 
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investigate their therapeutic properties and chemical structures. In accordance, based on the 
abundant medicinal plant resource and the great knowledge in utilizing these plants by the First 
Nation People in northern Ontario, there is great potential for drug discovery in this region.  
 
5. Thesis Objectives  
         Through a literature survey, no prior research on northern Ontario medicinal plants 
was identified. This presented me with a unique opportunity for ethnopharmacological research 
in this region for the treatment of infectious and oxidative stress related diseases. Hence, the 
objective of this thesis is to evaluate the in vitro antioxidant and antibacterial activity of twenty-
one northern Ontario medicinal plants. The medicinal plants were colected from the Thunder 
Bay region from a list of forty-eight northern Ontario medicinal plants (Table 1). The 
antioxidant activity is to be determined through DPPH, ABTS and ORAC assay and corelated 
with the total phenolic contents of medicinal plants. The antibacterial activity is to be determined 
through the hole-plate diffusion and minimum inhibitory concentration (MIC) assays against 
environmental isolates of Escherichia coli, Mycobacterium avium subsp. avium, Micrococcus 
luteus, Aeromonas caviae and Paenibacilus alvei bacterium. To elucidate the chemical 
characteristics of plant metabolites, crude extracts are to be further separated into varying 
fractions via gradient solvent manual liquid chromatography and analyzed in the MIC assay. 
Also, a few highly bioactive crude extracts are to be shortlisted and analyzed for the minimum 
bactericidal concentration (MBC) and time-kil analysis in order to provide incentive for future 
clinical investigations. 
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Figure 1: Chemical structures of bioactive compounds isolated from medicinal plants: Baicalein (1a), 
apigenin (1b) and baicalin (1c) isolated from the roots of Scutelaria baicalensis; Hyperforin (2) 
isolated from the aerial parts of Hypericum perforatum; Hypericin (3) isolated from the entire 
Hypericum perforatum plant; Polyyne (4) isolated from the root bark of Oplopanax horridus; 
Huperzine A (5) and lycopodine (6) isolated from the aerial parts of Lycopodium clavatum. 
 
Table. 1. List of 48 Northern Ontario medicinal plants. 
a. Filicinophyta  
Conventional 
Name 
Plant Family Botanical Name Medicinal Properties Potential Constituent(s) 
Clubmosses  Lycopodiacea
e: Clubmoss 
Lycopodium annotinum, L. 
clavatum, L. complanatum, 
L. dendroideum, L. 
inundatum, L. lucidulum, 
L. sabinifolium, L. selago, 
L. sitchense, L. 
tristachyum, L. x zeileri 
Antifungal, antibacterial, 
antiviral (Orhan et al. 
2007); relieve spasms, 
increase urine flow, 
estrogenic; reduce pain, 
fever, inflammation; 
insecticidal (Ainge et al. 
2002; Ibrahim et al. 
2001) 
Lycodine type alkaloids 
(Nagai et al. 2005), 
lycopodine alkaloids 
(Orhan et al. 2007), 
tetracyclic alkaloids (Yin 
et al. 2006), clavine 
alkaloid (Wink & 
Schneider 1990), 
huperizine A (Orhan et al. 
2007) 
Common 
Horsetail  
 
Equisetaceae:
Horse tail 
Equisetum arvense L., E. 
fluviatile L., E. palustre L., 
E. pretense Ehrh., E. 
sylvaticum L., E. 
variegatum. 
Teas used to treat gout, 
gonorrhea, stomach 
problems, bronchitis, 
tuberculosis and 
infection (Feresin et al. 
2003), antioxidant 
(Amarowicz et al. 2004) 
Antioxidant phenolics and 
proteins (Nagai et al. 
2005), saponins, alkaloids 
(Abascal & Yarnel 2008) 
b.  Plantae 
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Conventio
nal Name 
Plant Family Botanical Name Medicinal Properties Potential Constituent(s) 
Juniper Cupressaceae: 
juniper 
Juniperus communis L., J. 
horizontalis 
Treatment of pneumonia, 
fever, colds, coughs, 
rheumatic joints, 
inflammation, diarrhea; 
antimicrobial (Matovic et 
al. 1996) 
Tannins (Matovic et al. 
1996), alkaloids , 
terpenoids, flavonoids, 
sterols (Kumar et al. 2010; 
Wink 1987) 
White 
Spruce 
Pinaceae: pine  Picea glauca, P. mariana Used to treat infection 
(Jøhnk et al. 2005), 
insect bites, cuts (Jøhnk 
et al. 2005), scrapes 
Camphor (Roy & 
Bergeron 1990), 
polyphenolics (Ralph et al. 
2006), β-sitostarol 
(Dreikorn 2000), 
monoterpenes, 4-aly-
lansinol (Ibrahim et al. 
2001) 
Mossy 
Cup Oak 
Fagaceae: beech Quercus macrocarpa Used to treat diarrhea, 
toothaches, skin 
infections, cuts, sore 
throats, burns; has 
antiviral and antibacterial 
properties (Gülüce et al. 
2004) 
Tannins (De La Rosa et al. 
2001), phenolic acids 
(Cantos et al. 2003), 
polyphenols (Scalbert & 
Haslam 1987) 
Balsam 
Poplar  
Salicaceae: 
wilow 
Populous balsamifera L., 
P. tremuloides, P. 
grandidentata 
Used to treat diarrhea, 
fevers, skin problems, 
worms, inflammation; 
antimicrobial, antifungal 
(Isaeva et al. 2010; 
Mathes 1963)  
Monoterpenes (Bryant et 
al. 1992), sesquiterpenoids 
(Mates et al. 1987), 
phenolic glycosides 
(Mates et al. 1987), 
flavonoids (Isaeva et al. 
2010), tannins (Schimel et 
al. 1996) 
White Elm Ulmaceae: elm Ulmus americana L. Used to treat 
inflammation, diarrhea, 
burns, heartburn, 
antibacterial (Lee et al. 
1992), antifungal 
(Burden & Kemp 1984) 
Cerato ulmin (Richards & 
Takai 1988), phenolics 
(Witzel & Martín 2008), 
sesquiterpenes (Burden & 
Kemp 1984) 
Horse 
Chestnut 
Hippocastanaceae
: Buckeye 
Aesculus hippocastanum 
 
Used to treat blood 
circulatory problems and 
varicose veins; has anti-
edema, anti-
inflammatory, and free 
radical scavenging 
properties (Lou et al. 
2004); antimicrobial 
(Fant et al. 1999) 
Flavonoids (Kapusta et al. 
2007), saponins (Benthin 
et al. 1999), triterpenoid 
glycoside (Loew & 
Kaszkin 2002), 
polyphenols (Lou et al. 
2004), antimicrobial 
proteins (Fant et al. 1999) 
 
c.  Magnoliophyta  
Conventional 
Name 
Plant Family Botanical Name Medicinal Properties Potential Constituent(s) 
Quack Grass  
 
 
 
Elymus repens L.Z Antiseptic, laxative: used 
to treat fever, syphilis, 
jaundice, swolen and 
rheumatic limbs, chest 
DIBOA, vanilin, β-
hydroxybutyric-, 4-
hydroxycinnamic-, ferulic-
, vanilic-, syringic- and 
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Poaceae: grass pain, poor eyesight; 
afects crop development 
and reduce crop yields 
(An et al. 2005) 
protocatechuic acids (An et 
al. 2005); alelopathic 
aglycans (Hagen, 1989)  
Sweet Grass Hierochloe odorata Treat coughs, fever, 
venereal infections 
(Mohagheghzadeh et al. 
2006) 
Coumarin (Smal & 
Catling 1999), antioxidant 
(Kumar et al. 2010), 8-
dihydroxycoumarin 
(Krishnaiah et al. 2007) 
 
d.  Conipherophyta  
Conventional 
Name 
Plant Family Botanical Name Medicinal Properties Potential Constituent(s)  
Devil’s Club Apocynaceae: 
dog bane 
Oplopanax horridus Z Hypoglycemic (Large et 
al. 1938), antibacterial 
(Kobaisy et al. 1997), 
antiviral (Tai et al. 
2006), antioxidant 
(McCutcheon et al. 
1995); used to treat 
diabetes, colds, 
bronchitis, pneumonia; 
anticancer (Sun et al. 
2010) 
Polyynes (Kobaisy et al. 
1997); sesquiterpenoids 
(Smal & Catling 1999); 
hydrophobic anticancer 
metabolites (Sun et al. 
2010); diynes (Copp 
2003); phenolic glycosides 
(Huang et al. 2011) 
Dogwood or 
Bunchberry 
Cornaceae: 
dogwood 
Cornus canadensis L. Z, C. 
alternifolia, C. rugosa 
Lam., C. stolonifera 
Anti-inflammatory, 
fever-reducing, pain 
kiler; used to treat 
diarrhea, dysentery and 
burns, infections (Post & 
Urban 1995) 
Antioxidant phenolics 
(Mulabagal & Tsay 2004; 
Tanaka et al. 2003) 
Common 
Bearbery 
Ericaceae: 
heath 
Arctostaphylos uva-ursi Used to treat urinary 
tract infections, diarrhea, 
bladder problems, 
bronchitis, bleeding, 
cystitis (Abascal & 
Yarnel 2008); has 
antiseptic effects, anti-
bacterial (Betoni et al. 
2006; Puupponen-Pimiä 
et al. 2001), antioxidant 
properties (Amarowicz et 
al. 2004) 
Phenolic glycoside arbutin, 
tannins (Smal & Catling 
1999), antibacterial 
polyphenol (Betoni et al. 
2006), arbutin (Abascal & 
Yarnel 2008) 
Prince’s Pine Pyrolaceae: 
wintergreen 
Chimaphila umbelate Z Antimicrobial; used to 
treat infections, fevers, 
colds, sore throats, 
coughs, backaches, 
stomachaches, bladder 
problems, cystitis 
(Abascal & Yarnel 
2008) 
Antifungal compound 
(Galván et al. 2008), 
arbutin (Abascal & Yarnel 
2008) 
 
e.  Anthophyta  
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Conventional 
Name 
Plant Family Botanical Name Medicinal Properties Potential Constituent(s) 
Common 
Hops 
Cannabaceae: 
hemp 
Humulus lupulus Z Antibacterial; used to 
relieve tumors, 
pneumonia, wounds, 
toothaches, fevers, 
painful swelings, boils; 
anti-HIV (Yazaki et al. 
2009) 
α acids, β acids, prenylated 
chalcones (De Keukeleire 
et al. 2003); prenylated 
flavonoids, humulone and 
lupulone, phloroglucinol 
derivatives (Yazaki et al. 
2009) 
 
f.  Magnoliphyta  
Conventiona
l Name 
Plant Family Botanical Name Medicinal Properties Potential Constituent(s) 
Skunk 
Cabbage 
Ariceae Symplocarpus foetidus Z Treatment of epileptic 
seizures, applied to 
wounds, rheumatism; 
potentialy antifungal 
(Edilmesi 2002) 
Antifungal nitro 
compounds (Edilmesi 
2002) 
Sweet Flag Alismataceae: 
water plantain  
Acorus calamus L. Z CNS-depressent, anti-
inflammatory, 
antioxidant, 
antispasmodic, memory 
enhancing, antidiarrheal, 
anti-helmenthic; 
insecticidal (Varma & 
Dubey 1999) 
Phenylpropanes, 
monoterpenes, 
sesquiterpenoids, β-
asarone (Smal & Catling 
1999); phenolics 
(Gurevitch et al. 2002) 
Wild Onions 
and Wild 
Chives 
Liliaceae: lily  Alium schoenoprasum L., 
A. stelatum 
Used for treatment of 
cuts burns, insect bites, 
stings; Antibacterial, 
antiviral, antifungal 
(Kumari et al. 2009) 
Saponins (Benkeblia 
2004), phenolics (Barile et 
al. 2007) 
Spreading 
Dog Bane 
Papocynaceae: 
dog bane 
Apocynum 
androsaemifolium L., A. 
cannabinum L. 
Used to treat headaches, 
insomnia, constipation, 
indigestion, rheumatism, 
liver disease, syphilis; 
Antitumor properties 
(Murthy et al. 2011) 
Indole alkaloids (Murthy et 
al. 2011), monoterpenoid 
indole alkaloids (Mishra et 
al. 2006), latex (Jing-Yan 
& Zhao-Pu 2010) 
Wild Ginger Aristolochiace
ae: birthwort 
Asarum canadense L. Used to treat coughs, 
stomach problems, fever, 
gas, stomach upset and 
rashes; Antibacterial, 
antifungal properties 
(Yarnel & Abascal 
2008) 
Anti-adhesion compounds 
(Yarnel & Abascal 2008), 
chalcone and flavanol 
glycosides (Iwashina & 
Kitajima 2000); 
aristolochic acid alkaloids, 
borneol, α-pinene 
terpineol, elagic acid 
(Arnason et al. 1981) 
Swamp and 
Common 
Milkweed 
Asclepiadacea
e: milkweed 
Asclepias incarnate L., A. 
syriaca L. 
Used for treating 
blindness; stomachaches, 
asthma, bowel problems, 
rheumatism, intestinal 
worms; Milky sap 
applied to cuts and burns 
to infections and 
Latex containing surface 
cardenolides (Witstock & 
Gershenzon 2002) 
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irritations (Witstock & 
Gershenzon 2002) 
Common 
Yarrow 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asteraceae: 
sunflower 
 
Achilea milefolium L.  Antiseptic, antibacterial 
(Vasinauskiene et al. 
2006), anti-
inflammatory, anti-
spasmodic; used to treat 
diarrhea, urinary tract 
infections (Woods-
Panzaru et al. 2009) 
Isovaleric acid, camphor, 
azulenes, 
dehydromatracaria ester 
(Arnason et al. 1981); 
lactones, sterols, 
flavonoids (Arnason et al. 
1981) 
Black-eyed 
Susan and 
Wild 
Goldenglow 
Rudbeckia hirta L, R. 
laciniata L. 
Used to treat 
inflammation, 
indigestion, sores, 
snakebites, swelings, 
earaches; antimicrobial 
(Luczkiewcz & Cisowski 
2001) 
Polyacetylenes (Arnason et 
al. 1981); flavonoids, 
phenolic acids, 
anthocyanins (Luczkiewcz 
& Cisowski 2001); 
sesquiterpene lactones, 
pulchelin E (Luczkiewicz 
et al. 2002) 
Common and 
Rough 
Dandelion 
Taraxacum ceratophorum, 
T. oficinale 
Antimicrobial, lower 
sugar and cholesterol 
level, anti-inflammatory, 
immune stimulant; treat 
liver, urinary tract issues 
(Woods-Panzaru et al. 
2009) 
Sesquiterpene lactones 
(Michalska & Kisiel 
2003), phenolics (Hudec et 
al. 2007); Taraxacin, 
taraxerin,  
taraxerol, taraxasterol, 
inulin, gluten, gum, 
potash, choline, levulin, 
putin (Smal & Catling 
1999)  
Gumweed Grindelia squarrosa Used to treat bladder 
inflammation caused by 
fungi or food (Hofmann 
et al. 1993) 
Alkaloids (Hazlet & 
Sawyer 1998), diterpenes, 
polyphenolics (Hoffmann 
et al. 1993) 
Pearly 
Everlasting 
Anaphalis margaritacea Used to treat swolen 
mucus membranes, 
paralysis; have anti-
inflammatory, astringent 
efects; antimicrobial 
(Borchardt et al. 2008) 
Polyacetylenes, pentaynes 
(Borchardt et al. 2008) 
Canadian 
Goldenrod 
Solidago canadensis, S. 
multiradiata  
Used to treat 
rheumatism, neuralgia, 
headaches, sore throat, 
kidney stones, ulcers; 
contains antioxidant and 
antiseptic substances 
(Abascal & Yarnel 
2008) 
Flavonoids, glycosides, 
saponins (Abascal & 
Yarnel 2008); phenolic 
acids (Buchsbaum et al. 
1984) 
Cocklebur Xanthium strumarium L. Antibacterial, antifungal, 
antimalarial (Cerdeiras et 
al. 2007) 
Carboxyatractyloside 
(Cutler 1985); 8-epi-
tomentosin, xanthanolides 
(Park et al. 2001) 
Sweet 
Coltsfoot 
Petasites frigidus Inhibits bacterial growth; 
used to treat 
inflammation, sweling, 
burns, sores and skin 
diseases; anti-
Pyrrolizidine alkaloids 
(Smith & Culvenor 1981) 
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carcinogenic  
Chamomiles  Matricaria maritime L., 
M. matricarioides 
Antibacterial (Pastirova 
et al. 2004), anti-ulcer, 
antiviral, anti-
inflammatory (Pastirova 
et al. 2004) 
Sesquiterpenes, 
polyacetylenes, flavonoids, 
coumarins (Pastirova et al. 
2004) 
Blue Cohosh Berberidaceae: 
barberry 
Caulophylum 
thalictroides 
Used to treat pelvic 
inflammatory disease, 
colic, sore throat, 
inflammation, fevers, 
infections (Gotshal & 
Lucas 1949) 
Quinolizidine alkaloids 
(Roy & Bergeron 1990) 
Marsh 
Yelow Cress 
 
 
 
 
Brassicaceae: 
mustard 
 
Rorippa palustris Used to treat 
inflammation, infection, 
anemia, bronchitis 
(Bussmann et al. 2008) 
Isothiocyanates (Ishimoto 
et al. 2000), tropane 
alkaloids (Brock et al. 
2006), glucosinolates 
(Gurevitch et al. 2002) 
Shepherd’s 
purse 
Capsela bursa-pastoris May have anti-cancer 
substances (Daniel 2006) 
Flavonoids, glucosinolates, 
saponins, volatile oils and 
sulfur containing 
compounds (Daniel 2006); 
tropane alkaloids (Brock et 
al. 2006) 
Leaf Mustard 
and Wild 
Turnip 
Brassica juncea, B. rapa 
L. 
May have anti-cancer 
substances (Daniel 
2006); tonic for fevers, 
croup, asthma, 
headaches; antibacterial 
(Arnason et al. 1981) 
Tropane alkaloids (Jing-
Yan & Zhao-Pu 2010), 
glucosinolates (De La 
Rosa et al. 2001) 
Bitercress 
and 
Cuckooflowe
r 
Cardamine parviflora L., 
C. pensylvanica, C. 
pratensis L. 
Used to treat fevers, 
colds, sore throats, 
headaches, heart 
palpations, chest pains, 
gas, stomach upset, lack 
of appetite; may contain 
anti-cancer substances 
(Daniel 2006) 
Glucosinolates (Gurevitch 
et al. 2002), tropane 
alkaloids (Brock et al. 
2006) 
Sundews Droseraceae: 
sundew 
Drosera anglica, D. 
intermedia, D. linearis, D. 
rotundifolia 
Antibacterial, antiviral, 
antifungal, anticancer, 
used to treat coughs, 
aryngitis, pertussis, 
tracheitis, catarrh, 
tuberculosis, asthma, 
chronic bronchitis, 
ulcers, insecticidal 
(Bekesiova et al. 1999; 
Pareek et al. 2005) 
Polyphenolics (Bekesiova 
et al. 1999); 
naphthoquinones, 
plumbagin, flavonoids 
(Pareek et al. 2005) 
Gentians Gentianaceae: 
gentian 
Gentiana linearis, G. 
amarele; Gentianopsis 
crinite, G. detonsa 
Used to treat fever, 
indigestion, jaundice, 
skin diseases, heartburn; 
Antimicrobial properties 
(Dorman & Deans 2000) 
Secoiridoid glucosides-
gentiopicroside 
(Mulabagal & Tsay 2004) 
Common 
Geranium  
Geraniaceae: 
geranium 
Geranium bickneli Antiseptic (Dorman & 
Deans 2000), anti-
diuretic; used to treat 
Terpenoids, 
phenylpropanoid eugenol 
(Dorman & Deans 2000); 
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toothaches tannins and polyphenols 
(Scalbert & Haslam 1987) 
Northern St. 
Johns Wort 
Guteriferae: 
St. Johnswort  
Hypericum mutilum, H. 
perforatum, H. majus, H. 
elipticum, H. canadense  
Anti-inflammatory, 
antibacterial (Dal'Agnol 
et al. 2003); used to treat 
diarrhea, worms, coughs, 
depression, tuberculosis, 
tumors, cuts, ulcers, 
neurological disorders 
(Murch et al. 2003), 
cancer (Murch et al. 
2003) 
Hypericin, 
pseudohypericin, 
hyperforin (Murch et al. 
2003); phenolics, 
chlorogenic acid, 
quercitrin, quercitin, rutin, 
apigenin-7-O-glucoside 
(Çιrak et al. 2007) 
Heal-al  
Lamiaceae: 
mint 
Prunela vulgaris Antibacterial, antiviral, 
anti-inflammatory 
(Jirovský et al. 2007) 
Rosmarinic acid, phenolic 
acids (Jirovský et al. 
2007); ursolic acid, 
oleanolic acid (Wink 1987) 
Skulcaps Scutelaria galericulata L., 
S. lateriflora L., S. parvula 
Used to treat anticancer 
(Scheck et al. 2006); 
anti- inflammatory 
(Smith & Culvenor 
1981); antioxidant, 
anticonvulsant, 
antibacterial, anti viral 
(Shang et al. 2010) 
Flavonoids (Abascal & 
Yarnel 2008); baicalin, 
baicalein, wogonin (Murch 
et al. 2003), diterpenes 
(Shang et al. 2010), 
phenophorbide (Fajer et al. 
1992), apigenin (Sato et al. 
2000) 
Flax   
 
 
Linaceae: flax 
Linum perenne L., L. 
usitatissiumum L. 
Used to prevent breast, 
prostate and colon cancer 
(Hemmati et al. 2007)  
Justicidin B, glycosides of 
7-hydroxyjusticidin B 
(Hemmati et al. 2007); 
lignans, 
aryldihydronaphthalene 
(Hemmati et al. 2007); 
podophylotoxin (Hemmati 
et al. 2007) 
Fireweeds Onagraceae: 
evening 
primrose  
Epilobium angustifolium 
L., E. ciliatum, E. 
leptophylum, E. palustre 
L. 
Used to treat 
inflammation, burns, 
boils, sores, rashes, 
mouth ulcers, yeast 
infections (Iwashina & 
Kitajima 2000) 
Flavonoids, myricetin, 
sitosterol (Smal & Catling 
1999); tannins (Arnason et 
al. 1981), other phenolics 
(Romani et al. 2002), 3-O-
D-glucuronide (Romani et 
al. 2002)  
Sorrels Oxalidaceae: 
wood sorrel 
Oxalis acetosela L., O. 
stricta L.  
Used to treat 
inflammation, diarrhea, 
urinary tract infections, 
sprains, boils and 
pimples, traumatic 
injuries, infections 
(Feresin et al. 2003) 
Benzoquinones, phenols 
(Feresin et al. 2003); 
oxalic acid (Wink 1987) 
Bloodroot Papaveraceae: 
poppy 
Sanguinaria canadensis L. 
Z 
Used to treat vomiting, 
diarrhea, gas, 
stomachaches, ulcers, 
tuberculosis; 
antibacterial, antifungal, 
anti-inflammatory, 
antioxidant, antitumor 
(Arnason et al. 1981) 
Sanguinarine alkaloids 
(Arnason et al. 1981), 
Benzophenanthridine 
alkaloids (Arnason et al. 
1981)  
Plantains Plantaginaceae Plantago major L., P. Used to treat Iridoid glycosides aucubin 
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: plantain media L. inflammation, diarrhea, 
toothaches, headaches, 
bronchitis, sore throats, 
laryngitis, coughs, 
tuberculosis, infections 
(Jelager et al. 1998) 
and catalpol (Fajer et al. 
1992) 
Knotweeds 
and 
Smartweed 
Polygonaceae: 
buckwheat 
Polygonum archoreum, 
amphibium L., P. 
hydropiper L., P. 
lapathifolium L., P. 
pensylvanicum L., P. 
punctatum, P. scabrum, P. 
vivparum L. 
Known for treating 
various types of cancer 
(Yildirim et al. 2003); 
used to treat diarrhea, 
fever, chils, stomach 
pain, kidney problems, 
heart trouble, bleeding 
problems, antiseptic 
(Sato et al. 2000), 
antibacterial (Data et al. 
2000) 
Phenolcarboxylic acids, 
flavonoids, 
anthraquinones, stilbenes 
(Nonaka et al. 1982); 
sesquiterpene acid (Data 
et al. 2000) 
Pitcher Plant Sarraceniaceae
: pitcher plant 
Sarracenia purpurea L. May have anticancer, 
antiviral, antimicrobial 
properties (Etkin 2008) 
Conine alkaloids (Carlson 
et al. 1948); triterpenes, 
phytosterols, 
sesquiterpenes (Etkin 
2008) 
 
Z Rare plant species. This information was provided by Erika North, herbarium curator and contract 
lecturer at Lakehead University. 
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CHAPTER 2 
Antioxidant Activity of Twenty-One Northern Ontario 
Medicinal Plants  
Haider M. Hassan 
ABSTRACT 
There is a considerable demand in the pharmaceutical industry for natural antioxidants due to 
their low toxicity and protective effects in the human body. However, phytochemical research in 
the northern Ontario region is scarce, despite an abundance of medicinal plants utilized in Native 
Aboriginal communities. The present study investigates the in vitro antioxidant activity and total 
phenolic contents of 43 extracts from twenty-one northern Ontario medicinal plants. The 
antioxidant activity was evaluated through the DPPH (2,2-diphenyl-1-picrylhydrazyl), ABTS 
(2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt), ORAC (Oxygen 
radical absorption capacity), and EC50 (half maximal efective concentration) assays. Al extracts 
exhibit some level of antioxidant activity. The extracts from Cornus canadensis, Ledum palustre, 
Prunela vulgaris, Arctostaphylos uva-ursi, and Apocynum androsaemifolium L. display a high 
phenolic content and antioxidant capacity. The highest antioxidant activity is observed for the 
Cornus canadensis leaf extract with a value of 14.00  0.45 μg/ml, 177.95  3.95 μM TE/gdw, 
172.67  2.80 μM TE/gdw and 359.82  0.70 mg GAE/ 10 gdw for EC50, DPPH assay, ABTS 
assay and phenolic content, respectively. Overal, the observed bioactivities of these plants 
corelate with their usages in traditional medicinal practices in native aboriginal communities. 
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1. Introduction 
  Oxidative stress plays a critical role in the pathogenesis of many age related diseases, 
such as Alzheimer’s syndrome, cardiovascular diseases and cancer (Sohal & Weindruch 1996; 
Schumacker 2006; Markesbery 1997; Ou et al. 2012). Oxidative stress is propagated by radical 
molecules that exist in diferent forms, including superoxide ion (O2.), hydroxyl (HO.), 
hydroperoxyl radical (H2O2.), peroxyl radical (ROO.), singlet oxygen species (1O2), alkoxyl 
radical (RO.) and peroxynitrite (ONOO-) (Teow et al. 2007; Ou et al. 2002). Dietary antioxidants, 
enzymes and large molecules in healthy individuals stimulate celular defenses and neutralize 
free radicals (Prior et al. 2005). Among the isolated antioxidants, phenolic compounds are an 
especialy interesting group of molecules due to their ubiquity and pronounced protective effects 
(Orzechowski et al. 2002). Overal, epidemiological studies have demonstrated an inverse 
relationship between antioxidant rich diets and occurence of chronic diseases (Hertog et al. 
1993; Kaur & Kapoor 2008; Sánchez-Moreno et al. 1999). 
 Antioxidant compounds are also used in the food industry to prolong shelf life (Guilbert 
et al. 1996). A colective agreement entails that synthetic antioxidants, such as butylated 
hydroxyl-anisole (BHA) and butylated hydroxyl-toluene (BHT) pose higher toxicity and 
potential health risks relative to natural antioxidants (e.g. tocophenol and rosmarinic acid) (Kahl 
& Kappus 1993). In addition, natural antioxidants can be incorporated in our diet as 
nutraceuticals with health-promoting efects (Dilard & German 2000). Therefore, the search for 
antioxidants from natural sources has received atention. 
 In a previous investigation, I accumulated a list of 48 promising northern Ontario 
medicinal plants with claimed antioxidant, antibacterial, anticancer, anti-inflammatory and 
antiviral activity, among others. Through a literature survey, I found an absence of 
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ethnopharmacological research in this region despite an abundance of plant resources utilized in 
aboriginal communities for traditional medicinal practices. Hence, I selected twenty-one 
medicinal plants (from the original list of 48) from eleven plant families for the assessment of 
antioxidant capacities based on their ability to aleviate oxidative stress related diseases (i.e. 
cancer, inflammation) or claimed antioxidant activity (Table 1). In this study, I report on the 
total phenolic contents and in vitro antioxidant activity of the crude extract of these plants 
through DPPH (2,2-diphenyl-1-picrylhydrazyl), ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) diammonium salt), ORAC (Oxygen radical absorption capacity), and EC50 (half 
maximal efective concentration) assays.  
 
2. Results and Discussion 
 In this study, 21 northern Ontario medicinal plants were separated into leaf, flower, stem 
and root parts and extracted with ethanol. In total, 43 extracts from 21 medicinal plants were 
analyzed for their total phenolic contents and in vitro antioxidant activity to provide 
phytochemical evidence in support of their medicinal uses.  
 Antioxidant assays can be generaly divided into two major groups: Hydrogen Atom 
Transfer (HAT) or single Electron Transfer (ET). The ET-based methods (i.e. DPPH, total 
phenolic content, and ABTS assay) use the end-point of redox reaction to quantify antioxidant 
activity; whereas, the HAT-based methods (i.e. ORAC assay) utilize a competition based kinetic 
scheme between antioxidants, radical initiator (AAPH) and oxidizable probe (fluorescein) to 
quantify the antioxidant capacity (Huang et al. 2005). As such, the reaction rate diferences 
between antioxidants and radical species are not reflected in ET-based methods. Overal, no 
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single assay can provide a comprehensive analysis of antioxidant potential, thus, both ET and 
HAT-based methods were employed in this study (Table 2). 
2.1. DPPH Assay 
 The rate-determining step in DPPH assay involves a rapid electron transfer from the 
antioxidant to a DPPH* radical molecules (Foti et al. 2004). Upon reduction of the DPPH* 
radicals, the solution loses its deep violet color and this transition can be monitored at 517 nm. 
The antioxidant activity of 43 plant extracts in the DPPH assay range from 3.72 - 177.95 μM TE/ 
gdw, representing a variation of 48-fold. The leaf extract of C. canadensis displays the highest 
antioxidant activity, folowed by P. vulgaris leaf, L. palustre leaf, A. uva-ursi leaf, C. canadensis 
stem, and Apoc. androsaemifolium L. leaf extracts. The lowest activity was observed for S. 
purpurea L. leaf folowed by T. ceratophorum stem. According to a literature survey, high 
antioxidant capacity in the DPPH assay typicaly fals in the range of 90 - 100 μM TE/ gdw (Cai 
et al. 2005; Jastrzebski et al. 2007; Qin et al. 2011; Yao et al. 2010). Hence, antioxidant capacity 
above 80 μM TE/ gdw was considered significant in the present investigation. Among 43 
extracts, 31 (72%), 9 (21%) and 3 extracts (7%) exhibit antioxidant activity between 0 - 80, 80 - 
120 and 120 - 180 μM TE/ gdw, respectively. From the 12 extracts exhibiting antioxidant activity 
over 80 μM TE/ gdw, 75% belonged to the Apocynaceae, Sarraceniaceae, Ericaceae, Cornaceae 
and Lamiaceae plant families. Plants from Poaceae, Cupressaceae and Asclepiadaceae family 
exhibit moderate activity (between 60 - 80 μM TE/ gdw). The plant species from Onagraceae, 
Asteraceae and Lycopodiaceae families display low activity (mostly below 65 μM TE/ gdw). It is 
interesting to note that most extracts from the Asteraceae family display low antioxidant activity. 
Essential oils from plants of the Asteraceae family are known to contain antioxidant metabolites 
(Colombia 2010), however, many species from this family are reported to be weak scavengers of 
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the DPPH radical (Borneo et al. 2009; Miliauskas et al. 2004). A study by Borneo et al. (2009) 
on fifteen Argentinian species of Asteraceae family reported high EC50 values in the range of 
198.0 - 2009.7 μg/ ml.  
 EC50 value is defined as the extract concentration necessary to reduce 50% of the DPPH 
radical. The EC50 estimates of 43 extracts range from 14.00 - 235.42 μg/ml, representing a 
variation of 17-fold. The lowest EC50 value was observed for C. canadensis leaf, folowed by L. 
palustre leaf, P. vulgaris leaf, flower and stem, A. uva-ursi leaf and C. canadensis stem. The 
highest EC50 value was observed for T. ceratophorum stem. In accordance with prior studies (Cai 
et al. 2005; Mensor et al. 2001), plant extracts exhibiting EC50 below 30 μg/ ml were considered 
highly effective in neutralizing the DPPH radicals. In this study, only 9 extracts (21%) display 
EC50 values below 30 μg/ ml, with 77% of them belonging to the Ericaceae, Cornaceae and 
Lamiaceae families. It is exciting to note that the EC50 of C. canadensis (14.00 μg/ ml) was 
comparable to rutin (14.16 μg/ml) (Mensor et al. 2001), a dietary polyphenolic compound, which 
has reported protective effects against cancer (Alía et al. 2006), rheumatoid arthritis 
(Ostrakhovitch & Afanas'ev 2001) and other oxidative stress related diseases.  
2.2. ABTS Assay 
 ABTS*+ radical is generated by the persulfate oxidation of the ABTS 2- molecule in 
aqueous solution (Huang et al. 2005). The ABTS*+ radical is then reduced by antioxidants in 
mixture, resulting in a loss of green color. The antioxidant capacity of 43 plant extracts in the 
ABTS assay range from 7.00 - 172.67 μM TE/gdw, representing a variation of approximately 25-
fold. Highest antioxidant capacity was observed for C. canadensis leaf extract, folowed by the 
extracts of P. vulgaris leaf, L. palustre leaf, C. canadensis stem, Arct. uva-ursi leaf and Apoc. 
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androsaemifolium L. leaf. The lowest activity was found for Arctium lappa stem folowed by T. 
ceratophorum stem. Results from the ABTS assay are especialy interesting since absorption at 
734 nm exempts color interferences from sample (Dudonne et al. 2009). According to previous 
studies using similar ABTS method parameters, antioxidant activity in the range of 80 - 100 μM 
TE/ gdw is considered significant (Jastrzebski et al. 2007; Thaipong et al. 2006; Wojdyło et al. 
2009). Hence, 15 extracts (35%) display a significant antioxidant activity (greater than 80 μM 
TE/ gdw), with five of them exhibiting a capacity greater than 120 μM TE/gdw. Surprisingly, 
80% of the 15 promising extracts belong to Apocynaceae, Asclepiadaceae, Cupressaceae, 
Poaceae, Ericaceae, Cornaceae and Lamiaceae plant families. Onagraceae, Asteraceae and 
Lycopodiaceae families display low to medium activity (majority below 70 μM TE/ gdw), which 
is in agreement with DPPH assay. It is interesting to note that the leaf extracts from C. 
canadensis (Cornaceae), P. vulgaris (Lamiaceae) and L. palustre (Ericaceae) display an 
exceptional activity in both DPPH and ABTS assays.  
2.3. ORAC Assay 
 ORAC assay utilizes a radical initiator to generate peroxy radical (ROO*), which 
favorably abstracts hydrogen from antioxidants to form hydroperoxide (ROOH). This preference 
retards the oxidation of the fluorescent probe, generating an extract specific fluorescent decay 
curve. The ORAC assay value for 43 plants extracts range from 6.72 - 466.99 μM TE/gdw, 
representing a variation of approximately 69-fold. The highest activity in ORAC assay is 
observed for P. vulgaris leaf, folowed by P. vulgaris stem, Anap. margaritacea flower, Arct. 
uva-ursi leaf, Achi. milefolium L. flower, L. palustre leaf, Anap. margaritacea leaf, Achi. 
milefolium L. leaf and Arct. uva-ursi stem. The lowest value was observed for P. frigidus stem, 
folowed by R. hirta L. stem. Although, the data from diferent studies vary depending on 
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experimental parameters, an antioxidant capacity around 150 μM TE/ gdw can be considered 
significant (Oomah et al. 2008). From 43 extracts, 20 (46.5%), 12 (28%) and 11 extracts (25.5%) 
exhibit activity between 0 - 150, 150 - 300 and 300 - 470 μM TE/ gdw, respectively. Among the 
11 plant extracts exhibiting high antioxidant capacity (between 300 - 470 μM TE/ gdw), 64% of 
them belonged to Ericaceae, Lamiaceae and Cupressaceae plant families. Most plant extracts 
from Apocynaceae, Cornaceae, Sarraceniaceae, and Asclepiadaceae families display moderately 
high activity between 200 - 300 μM TE/ gdw. Plants from Lycopodiaceae and Onagraceae 
family exhibit low activity, which is consistent with ET-based assays. Interestingly, a 60-fold 
variation (6.72 - 404 μM TE/gdw) in activity was observed in plant species from Asteraceae 
family. In contrast to ET-based assays, extracts from Achi. milefolium and Anap. margaritacea 
plants of the Asteraceae family display an exceptionally high activity in the ORAC assay 
(between 210 - 404 μM TE/gdw). Furthermore, the C. canadensis leaf extract, which exhibited 
the highest activity in ET-based methods, displays only moderate activity in the ORAC assay. 
This discrepancy between ET and HAT-based methods has been reported in prior studies 
(Dudonne et al. 2009; Ou et al. 2002; Prior et al. 2005). According to Wright et al. (2001) and Ou 
et al. (2002), although HAT occurs simultaneously with ET mechanism, it plays a more dominant 
role in biological redox reactions. The ORAC assay also incorporates a biologicaly relevant 
radical source (ROO*), reaction scheme (competitive and Kinetic), temperature (37 oC), pH (7.4) 
and salinity system (Dudonne et al. 2009; Prior et al. 2005). Hence, it is both mechanisticaly and 
physiologicaly relevant. Overal, it is very exciting to report that extracts from P. vulgaris and L. 
palustre display among the highest antioxidant activity in both ET and HAT-based methods.  
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2.4. Total Phenolic Contents 
    In this assay, the folin-ciocalteu phenol reagent reacts with phenolic compounds under basic 
conditions to form chromogens that can be detected at 750 nm. The total phenolic contents of 43 
plant extracts range from 8.99 - 359.82 mg GAE/ 10 gdw, which represents a variation of 40-
fold. The leaf extract of C. canadensis exhibits the highest phenolic content, folowed by extracts 
of P. vulgaris leaf, L. palustre leaf, C. canadensis stem, Arct. uva-ursi leaf and Apoc. 
androsaemifolium L. leaf. The lowest phenolic content was found for Achi. milefolium L. stem, 
folowed by Ascl. incarnata L. stem and X. strumarium L. stem. Through a survey of literature, it 
was determined that phenolic contents around 100 mg GAE/ 10 gdw can be considered 
significant (Kähkönen et al. 1999; Javanmardi et al. 2003; Li et al. 2008; Turkmen et al. 2005), 
although higher quantities have been reported in literature (Ghasemi et al. 2009; Guo et al. 2011). 
From 43 extracts, 26 (60%), 9 (21%) and 8 extracts (19%) exhibit total phenolic contents 
between 0 - 100, 100 - 200, and 200 - 350 mg GAE/ 10 gdw. Furthermore, the diference in total 
phenolic contents between varying families was quite distinct. Seven out of eight extracts 
exhibiting high phenolic content (200 - 350 mg GAE/ 10 gdw) belong to Apocynaceae, 
Ericaceae, Cornaceae and Lamiaceae plant families. Most extracts from Asclepiadaceae, 
Sarraceniaceae, Poaceae and Cupressaceae families exhibit phenolic contents between 90 - 200 
mg GAE/ 10 gdw. Majority of species (81%) from Onagraceae, Asteraceae and Lycopodiaceae 
plant family exhibit low phenolic content (most below 80 mg GAE/ 10 gdw). These findings 
show great resemblance with ET-based methods. Surprisingly, X. strumarium leaf extract, which 
displays low activity in DPPH and ABTS assay, exhibits moderately level of phenolic content 
and antioxidant capacity in ORAC assay. 
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 Among the different parts of plants, the folowing hierarchy in total phenolic contents and 
antioxidant capacities was found, with a few exceptions: leaf > flower > root > stem. Leaf and 
flower tissues in plants generaly incur greater exposure to UV-B radiation from sunlight due to 
their higher surface areas for photosynthetic and mating purposes, respectively. As defense 
mechanisms, plants produce large quantities of phenolic metabolites (flavonoids, anthocyanin’s, 
quercetin glycoside) in these tissues to cope with oxidative stress (Cen & Bornman 2006; Price et 
al. 1995). A study by Price et al. (1995) demonstrated that concentration of the quercetin 
glycoside (a natural flavonol) in grapes tissue increased 7.5-fold (4.5 mg/L to 33.7 mg/L) as a 
direct outcome of increased exposure to sunlight. However, some plants, i.e. L. palustre, Apoc. 
androsaemifolium and C. canadensis, display high antioxidant and total phenolic contents despite 
flourishing in forest understory. As such, resistance to herbivore or competition against other 
plants in the habitat may be alternative hypothesis to explain the high antioxidant capacity and 
phenolic contents in these extracts. 
2.5. Correlation Analysis 
 Relationships between data from diferent assays were also analyzed in this study (Table 
3). High corelation between the ABTS and DPPH assays (r2 = 0.92, Figure 1 a) relates wel 
with an inter-laboratory finding that ABTS and DPPH are easy to implement, show high 
corelation and give reproducible results (Buenger et al. 2006). However, relatively weak 
corelation was observed between EC50, DPPH and ABTS assays (r2 = 0.69 and r2 = 0.63 with 
ABTS and DPPH assays, respectively, Figure 1 b). Insuficient incubation period in the EC50 
assay (30 minutes) may have inhibited atainment of the steady state kinetics for some plant 
species (Sánchez-Moreno et al. 1999). This may have implications in obscuring the EC50 
estimates, especialy for plants with weak antioxidant capacity, 
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 In this study, results from the ORAC assay display poor relationship with other radical 
scavenging assays and total phenolic contents (r2 = 0.32, r2 = 0.32, r2 = 0.40, and r2 = 0.45 with 
DPPH, ABTS, EC50 and total phenolic content assays, respectively, Figure 1 c, 1 d and 2 b). 
This discrepancy may be due to incorporation of a competition based kinetic reaction scheme or 
an alternate reaction mechanism inherent to HAT-based methods (Dudonne et al. 2009). Also, 
lack of solubilizing agents applied in the ORAC method could have confiscated activity of 
lipophilic phenolic groups in the aqueous medium (Cheng et al. 2006).  
 Relatively high corelations between the ET based antioxidant activity and total phenolic 
contents (r2 = 0.84, r2 = 0.85, r2 = 0.63 with ABTS, DPPH and EC50 assay, respectively, Figure 2 
a and 2 c) in plant extracts of our study conform to previous investigations (De-Oliveira et al. 
2009; Kontogianni & Gerothanassis 2012; Maisuthisakul et al. 2008). Indeed, phenolic 
compounds are excelent nucleophiles composed of one or more aromatic rings bearing hydroxyl 
groups that quench free radicals by forming resonance and steric stabilized phenoxyl radicals, 
inhibiting lipid peroxidation and acting as breakers of oxidation reaction (Bors & Michel 2002; 
Rice-Evans et al. 1996; Zou et al. 2011). 
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3. Materials and Methods 
3.1. Instruments and Chemicals 
 The absorbance was measured using Bio-Rad Smart Spec Plus spectrophotometer. 
Synergy HT Biotek using GEN 5 software was utilized for measurement of fluorescence.  The 
chemicals 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) diammonium salt (ABTS), 2,2'-Azobis(2-methylpropionamidine) 
dihydrochloride (AAPH), potassium persulfate, 6-hydroxy-2,5,7,8- tetramethylchroman-2-
carboxylic acid (Trolox), galic acid, Folin-Ciocalteu phenol reagent and anhydrous sodium 
carbonate were purchased from Sigma-Aldrich (USA). ACS grade methanol was purchased from 
Fisher Scientific (USA).  
3.2. Colection of Plant Material  
   Plant materials in this study were whole plant samples, including root and flower for 
some plants. They were colected during the late flowering season (June-August) in the Thunder 
Bay region, Ontario. The specimens were identified by Erika North, herbarium curator and 
contract lecturer at Lakehead University, Thunder Bay, ON, Canada. The scientific names were 
based on those proposed by Morton and Venn (1990). Al voucher specimens were deposited in -
80 oC fridge at the Bio-Refining Institute, Lakehead University.  
3.3. Extraction  
   The colected plant samples were separated into root, stem, flower and leaf parts. The 
plant parts were dried in dark over 24 - 48 hours at 32 oC. The dried plant samples (2 g) were 
ground up, miled through no. 40 mesh and extracted twice with 50ml of ethanol (95 % v/v) over 
Materials and Methods          Chapter 2: Antioxidant Activity 
 
 
42 
a period of 48 hours at room temperature. Al extracts were filtered through Whatman No.1 filter 
paper, evaporated to dryness in a rotary evaporator at 34 oC and stored at -80 oC in glass vials.  
3.4. ABTS antioxidant Assay  
   For ABTS assay, the procedure by Thaipong et al. (2006) was used with modifications. 
Stock solutions of 7.4 mM ABTS and 2.6 mM potassium thiosulfate were mixed in equal 
quantities and alowed to react in darkness at room temperature for 12 - 16 hours. Then, 1.0 ml of 
this working solution was mixed with 20 ml methanol to obtain a reading of 1.16 ± 0.05 units at 
734 nm. Plant extracts (150 μl) were alowed to react with 2850 μl of the diluted ABTS*+ for 2 
hours in dark. Then the absorbance was taken at 734 nM. This was done in triplicates and the 
results expressed as μM Trolox Equivalent/gram dry weight (μM TE/gdw). The Trolox standard 
curve was linear between 25 μM and 625 μM.  Negative control consisted of 150 μl of methanol 
in 2850 μl of the diluted ABTS*+ solution. 
3.5. DPPH Antioxidant Assay 
   The DPPH assay was performed according to the method established by Brand-Wiliams 
et al. (1995). The stock solution was prepared by dissolving 24 mg DPPH in 100 ml methanol. 
The working solution was prepared by mixing 10 ml of stock solution in 45 ml methanol to 
obtain a reading of 1.13 ± 0.05 at 515 nm. Plant extracts (150 μl) were alowed to react with 2850 
μl of DPPH working solution at room temperature for 24 hours in dark. The absorbance was read 
in triplicates at 515 nm and the results expressed as μM Trolox Equivalent/ gram dry weight (μM 
TE/gdw). The Trolox standard curve was linear between 25 μM and 825 μM. Negative control 
consisted of 150 μl of methanol in 2850 μl of the diluted DPPH solution. 
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3.6. Determination of EC50 
   This assay was performed according to Mensor et al. (2001). Briefly, 1 ml of freshly 
prepared 0.3 mM DPPH methanol solution was added to 2.5 ml of sample solution in triplicate, 
and alowed to react at room temperature for 30 minutes. The absorbance was measured at 518 
nm using methanol as blank. The EC50 value, extract concentration that can reduce 50 % of the 
initial DPPH radical concentration, was calculated through a dose-response curve expressed 
either as a linear or logarithmic relationship. DPPH solution (1.0 ml at 0.3 mM) plus methanol 
(2.5 ml) was used as a negative control and Trolox as positive control.  
3.7. Oxygen Radical Absorption Capacity Assay  
    The ORAC procedure was performed according to Teow et al. (2007). Briefly, 100 μl of 
12 nm fluorescein, 20 μl of methanol plant extract, and 80 μl of 24 mM AAPH (2,2'-Azobis(2-
methylpropionamidine) dihydrochloride) were loaded and mixed in flat botom, polystyrene 96-
wel microplate. The plate was agitated at slow speed for 15 seconds prior to first reading 
(excitation/ emission 485 nm/ 520 nm), in 1 min interval for 120 minutes at ambient conditions 
(pH 7.4, 37 oC). The area under the kinetic curve (AUC) was calculated using the PRISM 5 
software (Macintosh system) and the ORAC value was expressed as μM TE/ gdw. AAPH and 
fluorescein was used as blank, AAPH in exclusion was used as negative control and fluorescein 
in absence of AAPH and extract was the positive control.  
3.8. Total Phenolic Content (TPC) Assay  
    The total phenolic content assay was performed according to a procedure established by 
Ou et al. (2012). Briefly, at 0 min, 200 μl Folin-Ciocalteu phenol reagent was added to a reaction 
mixture of 200 μl of plant extract and 2.6 ml of ddH20 and mixed vigorously at room 
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temperature. After 6 minutes, 2 ml of 7 % anhydrous sodium carbonate solution were added and 
mixed vigorously. The mixture was incubated in dark for 90 minutes and absorbance was read at 
750 nm. The total phenolic content was expressed as mg Galic Acid Equivalent/ 10 gdw (mg 
GAE/ 10 gdw). The negative control consisted of 2.6 of ml ddH20, 200 μl Folin-Ciocalteu 
reagents and 200 μl of methanol.  
3.9. Statistical Analysis 
    The results were expressed as means  standard deviation (SD) of two or three replicate 
measurements. The standard errors and corelation coeficients were calculated in MS Excel and 
PRISM 5 software, respectively. 
 
4. Conclusion 
    My curent study establishes northern Ontario medicinal plants as promising candidates for 
ethnopharmacological research. In this study, 43 extracts from twenty-one northern Ontario 
medicinal plants were assayed for antioxidant activity through DPPH, ABTS and ORAC assays. 
The total phenolic content of medicinal plants was also determined. Al extracts exhibit some 
level of antioxidant activity and phenolic contents; however, a few were exceptional. In al 
assays, extracts from Ericaceae, Cornaceae and Lamiaceae family display exceptional 
antioxidant capacities and phenolic contents. Whereas, plant extracts from Onagraceae and 
Lycopodiaceae family consistently performed poorly. Plant extracts from the Asteraceae family 
typicaly ranked poorly, however, some extracts (especialy A. margaritacea) exhibit high 
phenolic content and remarkable activity in HAT and ET-based methods. Furthermore, phenolic 
content in medicinal plants corelated wel with their antioxidant profile in ET-based assays, 
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promoting phenolics as excelent agents in negating oxidative stress. Also, with a few exceptions, 
phenolic contents and antioxidant capacities in diferent parts of medicinal plants was observed 
in the folowing hierarchy: leaf > flower > root > stem. Overal, in this study, C. canadensis, P. 
vulgaris and L. palustre display the highest antioxidant capacities and phenolic contents. The 
present study provides strong evidences in supporting the medicinal properties and traditional 
uses of these plants. Curent investigation also promotes plant species from Ericaceae, 
Cornaceae and Lamiaceae families as model candidates in future phytochemical studies.  
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Table 1. Twenty-one northern Ontario medicinal plants and their medicinal properties. 
 
Table 2. Antioxidant capacities and total phenolic content of 21 northern Ontario medicinal plants 
 
Medicinal Plant Plant 
Part 
ABTS a (μM 
TE/ gdw) 
DPPH b (μM 
TE/ gdw) 
EC50 c (μg/ ml) ORAC d (μM TE/ gdw) 
Total Phenolic 
Content (mg 
GAE/ 10 gdw) 
Achi. milefolium L. Leaf  52.33  0.55  61.15  1.04 147.68  1.06 355.85  8.80  85.79  0.55 
Flower  43.11  0.25  49.74  1.01 114.86  0.61 385.16  0.57  92.74  1.07 
Stem  22.67  0.31  32.05  0.43 172.29  1.76 230.80  5.49   8.99  0.03 
Anap. margaritacea Leaf  80.02  0.66  80.77  1.61  86.14  0.67 370.77  4.35 120.10  2.34 
Flower  66.69  0.83  66.79  0.93 129.22  1.88 404.39  2.40 165.38  2.10 
Stem  23.36  0.14  22.31  0.21 150.00  8.89 118.38  6.67  25.24  0.11 
Apoc. 
androsaemifolium L. 
Leaf 104.44  0.96 110.13  3.11  34.46  0.46 210.14  5.64 239.96  4.58 
Stem  37.44  0.22  40.90  0.11 197.54  0.25  11.43  0.62  25.79  0.33 
Arct. uva-ursi Leaf 120.69  1.05 113.08  1.32  25.00  0.75 397.94  7.42 251.76  0.64 
Stem  90.24  0.55  84.36  0.09  30.15  1.16 344.47  3.93 206.63  3.40 
Arctium. lappa Leaf  30.78  0.16  20.38  0.34 151.68  2.34 133.63  18.63  62.18  0.31 
Flower  22.00  0.26  21.28  0.23 150.00  1.90  70.66  5.68  57.04  0.62 
Stem   7.00  0.15  20.51  0.42 187.50  8.19  21.27  0.51  18.71  0.11 
Ascl. incarnata L. Leaf  88.22  0.70  80.51  2.33  33.91  1.38 267.59  3.54  95.93  0.57 
Root  52.56  0.92  60.51  0.26 155.00  2.45  26.28  3.97  27.46  0.27 
Stem  50.56  0.41  26.67  0.55 169.47  0.56  11.12  0.09   9.68  0.02 
Plant Family Botanical Name Conventional Name Medicinal Property 
Asteraceae 
 
 
Achilea milefolium L. Common Yarrow Antimicrobial  
Anaphalis margaritacea Pearly Everlasting  
Arctium lappa Burdock Anti-inflammatory 
Grindelia squarrosa Gumweed Antibacterial, 
Petasites frigidus Sweet Coltsfoot Antibacterial 
Rudbeckia hirta L. Goldenglow Anti-inflammatory 
Solidago Canadensis Goldenrod Antiseptic  
Taraxacum ceratophorum Dandelion Antimicrobial  
Xanthium strumarium L. Cocklebur Antibacterial  
Ericaceae 
 
Arctostaphylos uva-ursi Common Bearberry Antibacterial  
Ledum palustre Labrador Tea Antibacterial, Anti-inflammatory 
Asclepiadaceae Asclepias incarnata L. Milkweed Antibacterial  
Apocynaceae Apocynum 
androsaemifolium L. 
Spreading Dog Bane Antibacterial 
Cornaceae Cornus Canadensis L. Dogwood Anti-inflammatory, anti-diarrheal,  
Onagraceae Epilobium angustifolium L. Fireweed Antibacterial  
Poaceae Hierochloe odorata Sweet Grass Antibacterial 
Cupressaceae Juniperus communis L. Juniper Antibacterial  
Lycopodiaceae Lycopodium annotinum, L. 
clavatum 
Clubmoss Estrogenic, antibacterial, antiviral,  
Lamiaceae Prunela vulgaris Heal-al Antibacterial, anti-inflammatory, 
Sarraceniaceae Sarracenia purpurea L. Pitcher Plant Antibacterial 
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C. canadensis L. Leaf  172.67  2.80 177.95  3.95  14.00  0.45 261.67  4.85 359.82  0.70 
Stem 127.11  0.48 112.69  0.95  27.50  0.96 220.64  5.54 256.35  0.13 
E. angustifolium L. Leaf  49.24  0.26  46.03  0.43  51.69  0.75 199.24  4.49  61.63  0.42 
G. squarrosa Leaf  35.33  0.13  64.87  0.32 172.29  1.87  40.03  0.90  78.01  0.62 
Flower  18.67  0.22  17.69  0.59 217.12  0.98  68.20  0.50  49.68  0.01 
Stem  51.67  0.47  47.56  1.57 166.67  3.28 101.72  1.87  35.93  0.30 
H. odorata Leaf  95.00  0.51  74.36  2.69 109.00  2.31  44.72  0.85 119.82  0.88 
J. communis L. Leaf  91.89  0.23  72.18  0.77  37.50  0.68 393.07  4.96 179.40  2.30 
L. palustre Leaf 157.33  2.13 161.54  3.05  15.00  0.06 376.76  8.92 349.81  1.90 
Stem  96.44  0.57  97.18  0.60  38.29  0.17 259.35  8.70 179.82  1.37 
L. annotinum Leaf  36.89  0.22  41.41  0.56 166.670.89 121.39  5.58  74.26  1.85 
L. clavatum Leaf  69.89  1.61  63.46  1.50 111.23  0.12  38.15  3.40  44.26  0.10 
Stem  57.78  0.24  62.44  1.01 101.320.46  58.50  3.14  47.32  0.15 
P. frigidus Leaf 57.56  0.37  44.62  0.80  35.00  1.80 226.26  3.02 128.85  1.84 
Stem  84.22  0.73  66.03  0.95  51.68  1.80  6.72  2.80 99.95  2.60 
P. vulgaris Leaf  160.00  1.57 169.23  4.70  17.23  0.97 466.99  5.80 350.65  3.27 
Flower  94.33  1.26  93.46  0.61  20.00  1.83 429.15  0.19 206.63  2.18 
Stem  98.89  5.91  67.95  0 .30  21.99  0.68 305.66  7.51 149.13  3.25 
R. hirta L. Leaf  46.11 1.21  40.64  0.54 189.99  0.15  11.27  0.51 29.96 
0.04 
Stem  68.67  0.16  65.51  1.41 127.98  3.98   9.17  0.051  44.96  0.04 
S. purpurea L. Leaf  25.11  0.57   3.72  0.08 179.52  0.30  99.64  5.96  26.90  0.31 
Root  78.22  0.39  87.56  2.69  37.29  0.26 266.47  4.54 161.35  0.89 
S. canadensis Leaf  35.36  0.61  35.90  0.33 144.11  5.60 264.03  9.00  42.60  0.16 
Stem   26.02  0.04  27.82  0.32 182.03  1.62  51.07  0.56  16.63  0.02 
T. ceratophorum Stem   8.44  0.07  7.44  0.04 235.42  5.47  60.36  7.26  33.85  0.23 
X. strumarium L. Leaf  67.91  0.61  53.72  0.11  35.65  0.90 195.93  5.76 149.40  0.42 
Stem   16.02  0.12  19.69  0.01 203.56  1.23  51.30  0.82  13.29  0.02 
Note: al results are expressed as mean  SD of three measurements 
a ABTS: 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt; b DPPH: 2,2-diphenyl-1-picrylhydrazyl; c 
EC50: concentration necessary to neutralize 50% of DPPH radical at concentration of 82μM; d ORAC: oxygen radical 
absorption capacity assay  
μM TE/ gdw: μM Trolox Equivalence/ gram dry weight  
mg GAE/ 10 gdw: mg Galic Acid Equivalence/ 10 gram dry weight. 
 
 
 
Table 3. Correlation between antioxidant capacities and total phenolic contents 
 
 
 
a TPC: total phenolic contents 
 
 Correlation Coefficient  
DPPH : ABTS 0.92 
DPPH : EC50 0.63 DPPH : ORAC 0.32 
DPPH : TPCa 0.85 
ABTS : EC50 0.69 ABTS : ORAC 0.32 
ABTS : TPCa  0.84 
ORAC : TPCa 0.45 
ORAC : EC50 0.40 EC50   : TPCa 0.63 
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Figure 1: Correlations between DPPH, ABTS, EC50 and ORAC assays in 43 extracts from 21 northern Ontario medicinal plants. a. A correlation coeficient of r2 = 0.92 was obtained between 
DPPH and ABTS assay data sets. b. The correlation coefficient between ABTS and DPPH 
assays versus EC50 values was r2 = 0.69 and r2 = 0.63, respectively. c. A correlation coeficient of r2 = 0.40 was obtained between EC50 values and ORAC assay data sets. d. 
Correlation coefficients of r2 = 0.32 was observed between DPPH, ABTS and ORAC 
assays.  
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Figure 2: Correlation between total phenolic content and radical scavenging assays (DPPH, ABTS, 
EC50 and ORAC) of 43 extracts from 21 northern Ontario medicinal plants. a. The correlation coeficient for DPPH and ABTS assay versus total phenolic content was r2 = 
0.84 and r2 = 0.85, respectively. b. Correlation coeficient of r2 = 0.45 was obtained between 
ORAC assay and total phenolic content. c. The correlation values between total phenolic 
content and EC50 assay was r2 = 0.63. 
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CHAPTER 3 
In vitro Antimicrobial Bioactivities of Twenty-One Northern 
Ontario Medicinal Plants  
Haider M. Hassan  
ABSTRACT 
Despite the abundance of medicinal plants in the northern Ontario region, the phytochemical and 
ethnobotanical investigations are scarce. In the present study, twenty-one northern Ontario 
medicinal plants were selected based on their uses in the treatment of inflammation, diarhea and 
infectious diseases in First Nation communities. The crude extracts of these plants were analyzed 
for in vitro antibacterial activity against six diferent bacterium through the hole-plate difusion 
and minimum inhibitory concentration (MIC) assays. Eight extracts were further shortlisted and 
analyzed for minimum bactericidal concentration (MBC) and time kil analysis. The crude 
extracts were also fractionated by polarity and analyzed in the MIC assay. Leaf and/ or flower 
extracts of Xanthium strumarium, Anaphalis margaritacea, Arctostaphylos uva-ursi, Apocynum 
androsaemifolium L., Cornus canadensis, Solidago canadensis and Grindelia squarrosa display 
the most promising activity. In the hole-plate diffusion assay, the Xanthium strumariumi leaf 
extract displays a larger zone of inhibition for Bacilus cereus than the ampicilin (100 μg/ml) 
positive control. In the MIC assay, majority of the extracts (62%) exhibit increased antibacterial 
activity in the medium polarity fraction. Particularly, the medium polarity fraction (Hex/ EtOAc/ 
MeOH 0:1:0) of Anaphalis margaritacea flower extract displays exceptional activity with 
bacterial inhibition at concentrations ranging from 0.08 - 1.25 mg/ml.  Also, crude extract of A. 
margaritacea displays MBC values ranging from 0.16 - 5 mg/ml against Aeromonas caviae, 
Micrococcus luteus, Bacilus cereus and Paenibacilus alvei. The extract was lethal to these 
bacteria within 1 - 8 hrs at MBC. Overal, the observed bioactivities of medicinal plants corelate 
with their uses in traditional medicinal practices.  
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1. Introduction 
 Infectious diseases are a major concern in our society. The impending problem is 
traceable to the evolution of multiple drug resistant strains of pathogenic bacteria and the 
concentrated use of existing antibacterial drugs (Ahmad et al. 1998). The agricultural industry 
also sufers from microbial infestations on crops, with plant pathogens causing an approximate 
20% reduction in crop yield per year worldwide (Oerke et al. 1994). The situation is especialy 
dire since the discovery of new chemical entities has been declining steadily and hit a 20 year 
low in 2001 (Newman et al. 2003). This may be atributed to the retraction of pharmaceutical 
research on natural products due to the advent of high throughput screening (HTS) technology 
and combinatorial chemistry (Butler 2008; Newman & Cragg 2007; Harvey 2008; Lam 2007). 
 In the areas of infectious diseases, 70% of al drugs originated from plant sources 
between 1981-2002 (Lam 2007; Newman et al. 2003). Medicinal plants are currently the focus 
of advanced contemporary research on their myriad bioactivities. However, phytochemical 
research was found to be vastly lacking in the northern Ontario region despite an established 
practice of traditional medicine by several native aboriginal communities.  
 In a previous investigation, I accumulated a list of 48 northern Ontario medicinal plants 
that exhibit anti-inflammatory, antibacterial, antioxidant, antiviral, anticancer and antidiarheal 
activity, among others. However, ethnopharmacological research on the antibacterial activity of 
medicinal plants in this region is limited. Hence, I selected twenty-one medicinal plants (Table 
1), from the original list of forty-eight, based on their uses in the treatment of burns, cuts, 
inflammation, infections, diarhea and mouth conditions. In accordance to North American First 
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Nations Ethnobotanical medicinal plants trend (Jones et al. 2000), plants utilized in aboriginal 
communities towards the treatment of these ilnesses may be the source of antibacterial 
phytochemicals. Here in, for the first time, I present a rigorous analysis of the in vitro 
antibacterial activity of these medicinal plants through the hole-plate difusion and minimum 
inhibitory concentration (MIC) assays. Crude extracts of these plants were also separated into 
fractions of varying polarity through manual liquid chromatography, and these fractions were 
assayed for their inhibitory activity in the MIC assay. The minimum bactericidal concentration 
(MBC) and time-kil analysis of a few short listed plants was also determined. 
 
2. Results and Discussion 
 In this study, twenty-one northern Ontario medicinal plants were selected based on the 
North American First Nations Ethnobotanical Medicinal Plant trend (Table 1). These plants were 
separated into leaf, flower, stem and root tissues and assayed for in vitro antibacterial activity 
through hole-plate difusion and MIC assays. A few short-listed medicinal plants were further 
assayed for MBC value and time-kil analysis.  
2.1. Hole-Plate Diffusion Assays  
 In hole-plate diffusion method, the active principle must difuse through the LB agar 
medium in a homogenous fashion to give optimal results (Rios et al. 1988). In order to lower the 
detection limit, inoculated system was kept at low temperature (4 oC) prior to incubation, which 
favors difusion in culture medium (Rios et al. 1988). The zone of inhibition (ZOI) was defined 
as the inhibition diameter around the hole (6 mm) in seeded agar plates. In this assay, 23 (53%) 
Results and Discussion        Chapter 3: Antimicrobial Activity 
 53 
out of 43 plant extracts from eight plant families (out of eleven) exhibit ZOI diameters in the 
range of 6.0 mm - 35.3 mm, representing a variation of approximately 6-fold (Table 2). The 
extracts of S. canadensis leaf, Arct. uva-ursi leaf and stem, Anap. margaritacea flower, stem and 
leaf, C. canadensis L. leaf and stem, G. squarrosa leaf and flower, Apoc. androsaemifolium L. 
leaf, E. angustifolium L. and P. frigidus leaf display the highest ZOI diameters. It is exciting to 
note that ZOI diameter from X. strumarium leaf extract for B. cereus was greater than the 
ampicilin positive control (100 μg/ml). The ZOI diameter for M. luteus, M. avium subsp. avium 
and P. alvei were comparable to ampicilin (100 μg/ml). The smalest inhibition zone of 6.0  1.5 
mm against M. avium subsp. avium was observed for the Achi. milefolium L. stem extract. 
Overal, only the extracts from C. canadensis L. leaf and Arct. uva-ursi stem and leaf, belonging 
to the Cornaceae and Ericaceae plant families, respectively, successfuly inhibit the growth of al 
six bacteria tested.  
 In previous investigations using similar methods, ZOI diameters in excess of 12 mm can 
be considered significant (Donaldson et al. 2005; Kudi et al. 1999; Palombo & Semple 2001). 
Plant extracts from Cornaceae and Ericaceae family display moderate to high antibacterial 
activity, with the majority of ZOI diameters around 14 mm. The leaf extracts of C. canadensis 
(Cornaceae) and Arct. uva-ursi (Ericaceae) exhibit the highest inhibition diameters for A. 
caviae, a Gram-negative bacterium. This finding is especialy intriguing since A. caviae 
demonstrates resistance to both chloramphenicol and ampicilin positive controls, a finding that 
conforms to prior studies on this bacteria (Vila et al. 2002). Plant extracts from Cupressaceae, 
Onagraceae, Lycopodiaceae and Asclepiadaceae families exhibit moderate to low antibacterial 
activity, with majority of ZOI diameters below 12 mm. However, plants from Asteraceae family 
exhibit the highest antibacterial activity, with majority of ZOI in the range of 15 - 35 mm 
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(Figure 1a). The Asteraceae family is composed of approximately 30,000 species belonging to 
over 1000 genera. This family is a rich source of sesquiterpenoids phytochemicals with 
documented antibacterial bioactivity (Wu et al. 2006). Particularly, the Xanthium genus is 
renowned for its use in alternative medicine for the treatment of infectious diseases (Anjoo & 
Ajay 2010). The antibacterial activity in Xanthium species has been atributed to the presence of 
xanthanolide sesquiterpenoids (i.e. xanthol and xanthanin) (Jawad et al. 1988; Sato et al. 1997). 
2.2. Minimum Inhibitory Concentration (MIC) Assay 
 Many clinical studies have demonstrated a dose-dependent corelation between antibiotic 
concentration and bacterial inhibition in liquid cultures (Schentag 1990). Hence, the MIC value 
sufices as a measure of eficacy of bioactive metabolites in their inhibitory action against 
specific bacteria. In the MIC assay, resazurin, a nontoxic and non-fluorescent dye, was used as an 
indicator of cel growth and viability. Resazurin, initialy dark blue, becomes pink and 
fluorescent when reduced to resorufin by oxidoreductases in living cels (Sarker et al. 2007; 
Mann & Markham 1998). It also generates a more distinct end-point color change than formazan 
based dyes and is relatively low cost (Grifin et al. 2000; Mann & Markham 1998). 
 In the MIC assay, thirty-seven (86%) out of 43 plant extracts inhibit the growth of one or 
more bacteria tested (Table 3). Plants from al families exhibit some level of activity. The 
extracts of S. canadensis leaf, X. strumarium leaf, Anap. margaritacea leaf and flower, Arct. uva-
ursi leaf, C. canadensis leaf, G. squarrosa leaf, stem and flower display the highest activity. 
Also, the extracts of C. canadensis L. leaf, Anap. margaritacea flower, Achi. milefolium L. leaf, 
S. canadensis leaf, X. strumarium leaf, P. vulgaris leaf, Ascl. incarnata L. leaf, Arct. uva-ursi 
stem and leaf successfuly inhibit the growth of al six bacteria tested. In prior studies, two-fold 
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serial dilution ranges of 0.38 - 12.6 mg/ml (Buwa & van Staden 2006; Eldeen et al. 2005), 0.64 - 
1.24 mg/ml (Yasunaka et al. 2005), 0.039 - 0.625 mg/ml (Mathabe et al. 2006) and 0.015 - 0.5 
mg/ml (Newton et al. 2002) have been reported for the MIC assay. However, at higher 
concentration (i.e. 12 mg/ml), solubility of the extract in liquid broth may be reduced, unless 
solubilizing agents are applied. Hence, a concentration range of 0.04 - 5.00 mg/ml was utilized in 
this study. Fractions exhibiting MIC values below 1.25 mg/ml were considered significant 
inhibitors of bacterial growth in liquid broth. From 37 plant extracts, six extracts (16%) from 
Asteraceae and Ericaceae plant families exhibit high antibacterial activity, with the majority of 
MIC values between 0.08 - 1.25 mg/ml (Figure 1b). Plant extracts from Poaceae, Cornaceae, 
Lamiaceae, Apocynaceae, Sarraceniaceae and Asclepiadaceae family show moderate 
antibacterial activity, with the majority of MIC values around 1.25 - 2.50 mg/ml. In concert with 
hole-plate difusion assay, plant extracts from Cupressaceae, Lycopodiaceae and Onagraceae 
plant families exhibit low antibacterial activity (majority of MIC values above 2.50 mg/ ml). 
Also, in agreement with hole-plate difusion assay, extracts from the Asteraceae plant family 
generaly display the highest antibacterial activity among al plant families. 
 In the MIC assay, a total of 4, 23, 2, and 1 extracts display increased antibacterial activity 
(i.e. lowest MIC values) in Hex/ EtOAc/ MeOH 5:1:0 (medium-low polarity), 0:1:0 (medium 
polarity), 0:9:1 (medium-high polarity) and 0:3:2 (high polarity) fractions, respectively. Hence, 
in the majority of extracts (62%), inhibitory activity was increased in the medium polarity 
fraction. This finding correlates with previous studies (Pekić et al. 1998; Swamy & Tan 2000; 
Syu et al. 1998), indicating that the ethyl acetate solvent shows a high selectivity towards natural 
products. This can be atributed to the accumulation of bioactive metabolites or the removal of 
potential antagonists. However, crude extracts of Achi. milefolium L. flower, C. canadensis leaf, 
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G. squarrosa flower, P. frigidus stem, Apoc. androsaemifolium leaf, Arct. uva-ursi and P. 
vulgaris stem demonstrate higher activities than individual fractions. The synergistic action of 
secondary metabolites in the crude extract has been reported in prior studies (Kohl et al. 1959; Si 
et al. 2006). A study by Kohl et al. (1959) demonstrated that the Piper methysticum crude extract 
was more efective in protection of the nervous system from strychnine (a toxic alkaloid) than its 
individual crystaline components. Also, Si et al. (2006) demonstrated that the Chinese green tea 
crude extract, which contains a mixture of compounds, displayed a higher degree of antibacterial 
activity than its individual components. Overal, none of the extracts display a significant 
antibacterial activity (MIC < 2.50 mg/ml) in the low polarity fraction (Hex/ EtOAc 9:1). 
2.3. Minimum Bactericidal Concentration (MBC) Assay and Time-Kil Analysis 
 MBC is the concentration of plant extract that completely exterminates bacterial growth. 
The MBC and time-kil assay was performed on the crude extracts of most promising medicinal 
plants belonging to Asteraceae, Apocynaceae, Ericaceae and Cornaceae plant families. These 
extracts were selected due to their high tier performance in the hole-plate difusion and MIC 
assays (refer to Figure 1). 
 In the MBC assay, none of the extracts achieved extermination of E. coli and M. avium 
subsp. avium bacteria (Table 4). Among the bacteria that were complete annihilated by the 
shortlisted plants, A. caviae requires the highest bactericidal concentration, which may be 
atributed to a diference in cel wal bariers characteristic of al Gram-negative bacteria. In the 
time-kil analysis, most of the plant extracts proved lethal to A. caviae, M. luteus and P. alvei at 
MBC between 1 - 12 hours (Figure 2). In most cases, extracts of Arct. uva-ursi leaf, G. 
squarrosa flower and leaf and A. margaritacea flower were able to exterminate the bacteria 
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tested between 1 - 4 hrs. Particularly, the extract of A. margaritacea flower displays complete 
kil within 2 - 8 hours at bactericidal concentration of 0.16 mg/ml and 1.25 mg/ ml for P. alvei 
and M. luteus, respectively. Extract of A. margaritacea flower exterminated A. caviae within 1 hr 
at 5 mg/ml. However, none of the shortlisted extracts proved lethal to B. cereus at their 
respective MBC values; instead, a bacteriostatic effect was observed. Similar finding has been 
reported in prior studies (Ahmed et al. 2004; Viljoen et al. 2005), suggesting that B. cereus may 
develop resistance when grown in favorable conditions.  
 Among the shortlisted medicinal plants, a detailed time-kil analysis was performed on 
Anaphalis margaritacea flower extract due to its high bioactivity (Figure 3). Anaphalis 
margaritacea flower extract achieved maximum kil for B. cereus at 3 X MBC, whereas, at MIC, 
MBC and 2 X MBC a bacteriostatic effect was observed (Figure 3b). The time kil analysis for 
P. alvei was of particular significance, since the extract was able to achieve maximum kil at a 
concentration of 80 μg/ml (MIC) within 2 hrs (Figure 3c). As expected, at higher concentrations 
of the extract (i.e. 3 X MBC and 2 X MBC) complete kil for P. alvei was observed within 1 hr 
or less. Findings in this study ilustrate the high potency of this extract, especialy against Gram-
positive bacteria.  It is exciting to note that A. margaritacea flower extract from Asteraceae 
family also exhibits considerably low MIC values (between 0.08 - 1.25 mg/ml) in the medium 
polarity fraction (Hex/ EtOAc/ MeOH 0:1:0). The antibacterial activity in this plant may be 
atributed to the presence of hydroxylactones (Ahmed et al. 2004). However, future studies need 
to be geared towards elucidating the exact source of its bioactivity.  
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2.4. Relationship Between Hole-plate Diffusion and MIC Assay 
 In the antimicrobial assays, fourteen plants that display no ZOI, exhibit activity in MIC 
assays. This discrepancy may be atributed to the difusibility of the secondary metabolites in 
hole-plate difusion assay, which is influenced by their size, polarity, conformation and ionic 
charge (Griffin et al. 2000). The ability of bioactive metabolites to difuse through the agar 
medium may have also construed corelation between the two assays. For instance, X. 
strumarium, which displays the largest ZOI diameter in hole-plate difusion assay, exhibits 
significantly higher MIC values relative to Anap. margaritacea and S. canadensis. Due to these 
chalenges, many studies primarily consider the data from agar-difusion method as preliminary 
and a qualitative evidence of antibacterial activity (Fernández-Pan et al. 2012). In broth dilution 
assays, the presence of organic solvents aid in the solubilization of non-polar metabolites and 
provide a significantly more accurate analysis of antimicrobial activity (Grifin et al. 2000). 
Broth dilution methods are also more quantitatively relevant since inhibitory action of bioactive 
metabolites is not determined by its difusibility, but rather solubility in media and specific 
interaction with the target microorganism. However, a general corelation between high ZOI 
diameter and low MIC values, and vice versa, was observed. Majority of plants from Asteraceae, 
Ericaceae and Cornaceae family that display relatively high ZOI diameter also exhibit low MIC 
values. Further, plants from Cupressaceae, Lycopodiaceae and Onagraceae family that display 
relatively low ZOI diameters also exhibit high MIC values.  
2.5. Bacterial Susceptibility 
 In the hole plate difusion method, a total of 7, 23, 16, 17, 12 and 12 plant extracts 
inhibited the growth of E. coli, B. cereus, M. avium subsp. avium, M. luteus, A. caviae and P. 
Results and Discussion        Chapter 3: Antimicrobial Activity 
 59 
alvei, respectively. In the MIC assay, E. coli and A. caviae display the least sensitivity to extracts 
with the lowest observed MIC of 1.25 mg/ml. The highest sensitivity was displayed by P. alvei 
and M. luteus with the lowest observed MIC of 0.08 mg/ml and 0.31 mg/ml, respectively. This 
finding corelates wel with previous studies (Kudi et al. 1999; Olano et al. 1996; Palombo & 
Semple 2001; Vlietinck et al. 1995) indicating that the Gram-negative bacteria are more resistant. 
This innate resistance can be atributed to a diference in cel wal structure, with the outer 
membrane of Gram-negative bacteria providing a protective barier against antibiotics, detergents 
and many other environmental substances (Palombo & Semple 2001). Interestingly, P. alvei 
presented superior resistance on solid agar media, in contrast to liquid media. This may be 
atributed to the production of a lipopeptide derivative biosurfactant front on solid media by P. 
alvei that confers higher resistance to bactericides (Najafi et al. 2011). Overal, in my data there 
was no uniform response within or between bacterial strains in terms of susceptibility to the 
antibacterial substances in methanolic extracts of the medicinal plants. This may be atributed to 
diferences in cel wal composition, inheritance genes, or plasmids that can be transmited 
between bacterial species.  
 Species of E. coli, M. avium and A. caviae are potentialy pathogenic to humans causing 
fevers, gastro-intestinal and extra-intestinal infections, mal-absorption, diarrhea, food poisoning, 
wound infections and bacteremia (Awan et al. 2009; Vila et al. 2003; von Reyn et al. 1994; 
Welch et al. 1981). Interestingly, A. caviae displays high resistance to the β lactam and 
cephalosporin antibiotics (i.e. ampicilin, cefazolin), though clinical isolates are more of a 
concern than environmental isolates (Awan et al. 2009; Ko et al. 1996; Vila et al. 2002; Vila et 
al. 2003). Further, B. cereus and P. alvei are food-borne pathogen and causative agent of 
foulbrood in honeybees, respectively (Antúnez et al. 2012; Ultee et al. 1998). Though, M. luteus 
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is a commercial strain, it can also be an opportunistic pathogen in patients with AIDS or 
immune-deficiency (Peces et al. 1997). Curent study identifies several medicinal plants that 
could be a source of potential antibiotics or new chemical entities for agricultural crop protection 
programs or treatment of infectious diseases caused by these bacterium. 
 
3. Materials and Methods 
3.1. Instruments and Chemicals 
 Resazurin was purchased from Sigma-Aldrich (USA). Sodium chloride, potassium 
chloride, sodium bisphosphate, potassium phosphate monobasic, methanol, yeast extract, 
phytone and peptone were purchased from fisher scientific (USA).  
3.2. Test Microorganisms 
 The microorganisms tested were al environmental isolates. They were representative of 
Gram negative, Gram positive, aerobic and facultative anaerobic categories. They comprised of 
Bacilus cereus, Escherichia coli, Micrococcus luteus, Mycobacterium avium subsp. avium, 
Paenibacilus alvei and Aeromonas caviae. They were streak plated on LB agar and maintained 
at 4 oC in dark. Stock freezer cultures were kept at -80 oC.  
3.3. Colection of Plant Material  
 The plant materials in this study were whole plant samples, including root and flower for 
some plants. They were colected during the late flowering season (June-August) in Thunder 
Bay region, Ontario. The specimens were identified by Erika North, herbarium curator and 
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contract lecturer at Lakehead University, Thunder Bay, Ontario. The scientific names were based 
on those proposed by Morton and Venn (1990). Al voucher specimens were deposited in -80 oC 
fridge at the Bio-Refining Institute, Lakehead University. 
3.4. Extraction and Separation 
 The colected plant samples were separated into root, stem, flower and leaf parts. The 
plant parts were dried in dark over 24 - 48 hours at 30 oC. The dried plant samples (2 g) were 
ground up, miled through no. 40 mesh and extracted twice with 50 ml of ethanol (85% v/v) over 
a period of 48 hours at room temperature. Al extracts were filtered through Whatman No. 1 filter 
paper, evaporated to dryness under rotary evaporator at 34 oC and stored at -80 oC in glass vials.  
 The extracts were subjected to manual LC on silica gel (40-60μm; 1 x 14cm) using Hex/ 
EtOAc/ MeOH 9:1:0, 5:1:0, 0:1:0, 0:9:1, 0:3:2, 5ml/min, in 100 ml aliquots. Al fractions were 
dried in a rotary evaporator and high vacuum for 24 hours, and stored at -80 oC.  
3.5. Hole-Plate Diffusion Assay 
 The procedure was folowed according to Galo and Riera (2005) with modifications. In 
this assay, 100 μl of 2x106 CFU/mL bacterial suspensions were homogenously seeded into 25 ml 
of liquid broth agar and poured into 100 mm petri dishes. Then, 6 mm holes were asepticaly 
bored into agar and 40 μl of 10 mg/ml methanolic extracts were pipeted into the wels. The 
plates were kept at 4 oC for 3 hours, then, incubated at 32 oC for 18 - 20 hours in dark. 
Chloramphenicol (100 μg/ml) and ampicilin (100 μg/ml) were used as positive controls and 
methanol was used as negative control. Al results were recorded as mean of the triplicate and the 
zones of inhibition were determined as the diameter of inhibition zones around the holes.  
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3.6. MIC and MBC Assay 
 The minimum inhibitory concentration (MIC) assay was performed according to Sarkar et 
al. (2007) with modifications. First and second fractions from each extract were dissolved in 
EtOAc/ MeOH 6:1, whereas, the rest of fractions were dissolved in methanol (99.85 % v/v). The 
extracts were re-suspended to a concentration of 20 mg/ml. Then, 50μl of 20 mg/ml extract was 
asepticaly added to 230 μl of LB broth in the first wel of a sterile 96 wel micro-plate. To each 
subsequent wel, 180 μl of LB broth was added. Two fold serial dilutions, in 100 μl aliquots, 
were performed using a multichannel pipete to achieve a concentration gradient of 5.00 - 0.04 
mg/ml. Prior to each subsequent dilution, precaution was taken to maximize homogeneity of the 
solution. Then, 20 μl of 2 x 106 CFU/ml bacterial suspensions in 1X PBS bufer were inoculated 
in their respective wels (to a final volume of 200 μl), the plate was wrapped with parafilm and 
placed in a plastic bag with mildly wet paper towel to prevent dehydration of bacteria. The plates 
were incubated at 32 oC for 18 hours in dark. After incubation, 10 μl of 0.04% resazurin in 1 X 
PBS bufer was added and the plate was further incubated in dark at 32 oC for 90 - 180 minutes. 
Micro-plates were viewed under short wavelength UV lamp for fluorescence and color change. 
The lowest concentration in which color changed from blue to pink, and displayed fluorescence, 
was taken as MIC. The MBC value was determined by plating 15 μl aliquots from wels without 
visible growth. Wels exhibiting complete annihilation of bacteria after incubation of LB agar 
plates at 32 oC for 18- 24 hrs were taken as MBC. A two-fold serial dilution of chloramphenicol 
(100 μg/ ml) and ampicilin (100 μg/ml) were used as positive controls, and EtOAc/ MeOH 6:1, 
0:1 as negative control.  The tests were performed in duplicates.  
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3.7. Time-Kil Analysis 
 Time-kil analysis was performed according to Imazatol et al. (1999). Bacterial 
suspensions prepared in 1 X PBS bufer were added in 2 ml of LB broth to a final concentration 
of 2x106 CFU/ ml. The LB broth was prepared with a certain concentration of plant extracts and 
incubated at 30 oC with shaking at 200 rpm. After 30 min, 1 hr, 2 hr, 4 hr, 8 hr, 12 hr and 24 hr of 
incubation, 40 μl aliquot was acquired, serialy diluted and plated on LB agar. The plates were 
incubated at 32 oC for 18 - 24 hrs and the numbers of viable cels were determined by counting 
the colonies. The test was performed in duplicates.  
3.8. Statistical Analysis 
 The results were expressed as means  standard deviation (SD) of two or three replicate 
measurements. The standard error was calculated in MS Excel v. 2011. 
 
4. Conclusion 
 In conclusion, this study promotes northern Ontario region as a promising candidate for 
future ethnopharmacological research. In this study, 43 extracts from twenty-one northern 
Ontario medicinal plants were subjected to hole-plate difusion and MIC assays to determine 
their antibacterial activity. Plants from eight families (out of 11) display activity in the hole-plate 
difusion assay; however, extracts from al families exhibit activity in the MIC assay. Also, al 
extracts that actively inhibit bacteria in hole-plate difusion assay show activity in the MIC assay. 
Plants from the Asteraceae, Ericaceae and Apocynaceae families display the highest antibacterial 
activity; whereas, plants from the Cupressaceae, Lycopodiaceae and Onagraceae families 
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display relatively low ZOI diameters and high MIC values. In the hole-plate difusion and MIC 
assay, only the extracts from C. canadensis leaf and A. uva-ursi stem and leaf successfuly inhibit 
the growth of al six bacteria tested. In the MIC assay, a majority (62%) of the extracts exhibit 
increased activity in their medium polarity fraction (Hex: EtOAc: MeOH 0:1:0). Further, in both 
MIC and hole-plate diffusion assays, plant extracts from G. squarrosa, X. strumarium, A. 
margaritacea and A. uva-ursi display among the highest antibacterial activity. In the MBC and 
time-kil analyses, the flower extract of Anap. margaritacea exterminated B. cereus, A. caviae, P. 
alvei and M. luteus within 2-8 hours at a concentration range of 0.08 - 2.50 mg/ml. Overal, the 
observed bioactivities of medicinal plants provide evidence for their traditional medicinal uses in 
native Aboriginal communities. 
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Table 1. Twenty-one northern Ontario medicinal plants and their medicinal properties.  
 
 
 
 
Table 2. Hole-plate diffusion assay of 21 northern Ontario Medicinal Plants. 
 
Medicinal Plant Plant 
Part 
Zone of Inhibition Diameter** (mm) 
Gram Negative  Gram Positive  
E. coli a A. caviae b B. cereus c M. luteus d M. avium e P. alvei f 
Achi. milefolium 
L. 
Leaf (-) 14.0  0.0 (-) (-) 12.0  2.0 (-) 
Flower (-) 16.0  0.0 (-) (-) 9.3  1.2 8.0  0.0 
Stem (-) (-) (-) (-) 6.0  1.5 (-) 
Anap. 
margaritacea 
Leaf (-) (-) 22.7  3.1 19.3  1.2 18.6  1.2 (-) 
Flower (-) 22.0  1.2 21.3  3.1 19.3  1.2 22.7  1.2 23.0  1.2 
Stem (-) 20.0  0.0 14.7  3.1 13.3  2.3 16.0  2.0 (-) 
Apoc. 
androsaemifolium 
L. 
Leaf 15.3  1.2 (-) 9.3  1.2 (-) 16.0  2.0 (-) 
Stem (-) (-) (-) (-) (-) (-) 
Arct. uva-ursi Leaf 16.6  1.2 30.0  0.0 16.7  2.3 17.3  1.2 18.0  2.0 15.0  0.0 
Stem 9.3  1.2 22.0  0.0 10.7  2.3 10.0  0.0 12.7  4.6 12.0  0.0 
Arctium lappa Leaf (-) (-) (-) (-) (-) (-) 
Flower (-) (-) (-) (-) (-) (-) 
Stem (-) (-) (-) (-) (-) (-) 
Ascl. incarnata L. Leaf 11.3  1.2 (-) 10.0  0.0 (-) 11.3  1.2 (-) 
Root (-) (-) (-) (-) (-) (-) 
Stem (-) (-) (-) (-) (-) (-) 
C. canadensis L. Leaf 11.3  1.2 26.7  1.2 11.3  1.2 14.7  3.1 11.3  1.2 12.0  0.0 
Stem 10.0  0.0 (-) 12.0  5.3 9.7  0.6 12.7  1.2 20.0  0.0 
Plant Family Botanical Name Conventional Name Medicinal Property 
Asteraceae 
 
 
Achilea milefolium L. Common Yarrow Antimicrobial  
Anaphalis margaritacea Pearly Everlasting  
Arctium lappa Burdock Anti-inflammatory 
Grindelia squarrosa Gumweed Antibacterial, 
Petasites frigidus Sweet Coltsfoot Antibacterial 
Rudbeckia hirta L. Goldenglow Anti-inflammatory 
Solidago Canadensis Goldenrod Antiseptic  
Taraxacum ceratophorum Dandelion Antimicrobial  
Xanthium strumarium L. Cocklebur Antibacterial  
Ericaceae 
 
Arctostaphylos uva-ursi Common Bearberry Antibacterial  
Ledum palustre Labrador Tea Antibacterial, Anti-inflammatory 
Asclepiadaceae Asclepias incarnata L. Milkweed Antibacterial  
Apocynaceae Apocynum 
androsaemifolium L. 
Spreading Dog Bane Antibacterial 
Cornaceae Cornus Canadensis L. Dogwood Anti-inflammatory, anti-diarrheal,  
Onagraceae Epilobium angustifolium L. Fireweed Antibacterial  
Poaceae Hierochloe odorata Sweet Grass Antibacterial 
Cupressaceae Juniperus communis L. Juniper Antibacterial  
Lycopodiaceae Lycopodium annotinum, L. 
clavatum 
Clubmoss Estrogenic, antibacterial, antiviral,  
Lamiaceae Prunela vulgaris Heal-al Antibacterial, anti-inflammatory, 
Sarraceniaceae Sarracenia purpurea L. Pitcher Plant Antibacterial 
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E. angustifolium L. Leaf 9.0  0.0 22.0  0.0 10.0  0.0 10.0  0.0 10.0  0.0 (-) 
G. squarrosa Leaf (-) 18.0  0.0 15.0  1.0 19.3  1.2 13.3  1.2 15.3  0.6 
Flower (-) 21.3  1.2 19.3  2.3 23.3  1.2 15.0  1.0 16.0  0.0 
Stem (-) (-) (-) (-) (-) (-) 
H. odorata Leaf (-) (-) (-) (-) (-) (-) 
J. communis L. Leaf (-) (-) 8.7  1.2 11.3  1.2 10.7  1.2 20.0  0.0 
L. palustre Leaf (-) (-) (-) (-) (-) (-) 
Stem (-) (-) (-) (-) (-) (-) 
L. annotinum Leaf (-) (-) (-) 12.7  1.2 12.0  0.0 (-) 
L. clavatum Leaf (-) (-) (-) 8.0  0.0 7.3  1.2 (-) 
Stem (-) (-) (-) (-) 8.7  1.2 (-) 
P. frigidus Leaf (-) 14.0  0.0 12.0  0.0 8.0  0.0 8.7  1.2 (-) 
Stem (-) (-) (-) (-) (-) (-) 
P. vulgaris Leaf (-) (-) (-) (-) (-) (-) 
Flower (-) (-) (-) (-) (-) (-) 
Stem (-) (-) (-) (-) (-) (-) 
R. hirta L. Leaf (-) (-) (-) (-) (-) (-) 
Stem (-) (-) (-) (-) (-) (-) 
S. purpurea L. Leaf (-) (-) (-) (-) (-) (-) 
Root (-) (-) (-) (-) (-) (-) 
S. canadensis Leaf (-) (-) 12.0  2.0 13.3  4.2 14.0  1.2 12.0  0.0 
Stem  (-) 16.0  0.0 (-) 14.0  0.0 (-) 9.0  0.0 
T. ceratophorum Stem (-) (-) (-) (-) (-) (-) 
X. strumarium L. Leaf (-) (-) 26.7  1.2 35.3  1.2 30.0  1.2 25.0  1.2 
Stem  (-) (-) (-) (-) (-) (-) 
Chloramphenicol 
(100μg/ml) 
32.0  0.0 (-) 42.0  0.0 52.0  0.0 50.0  0.0 50.0  0.0 
Ampicilin(100μg/ml) 30.0  0.0 (-) 22.0  0.0 44.0  0.0 36.0  0.0 36.0  0.0 
99.99% MeOH (40μl) (-) (-) (-) (-) (-) (-) 
Note: al results are expressed as mean  SD of three measurements. 
(-): No zone of inhibition was observed. 
a Escherichia coli; b Aeromonas caviae; c Bacilus cereus; d Micrococcus luteus; e Mycobacterium avium subsp. 
avium; f Paenibacilus alvei 
** The Zone of Inhibition is defined as the inhibition diameter around the 6 mm holes bored in the agar 
 
 
 
Table 3. Minimum inhibitory concentration of 21 northern Ontario medicinal plants 
 
Medicinal 
Plant 
Plant 
Part 
Fraction Minimum Inhibitory Concentration (mg/ml) 
Gram Negative Gram Positive 
E. coli f A. caviae g B. cereus h M. luteus i M. avium j P. alvei k 
 
 
 
 
 
Anap. 
margaritacea 
 
 
 
 
 
Leaf C 
a, b A >5 
c >5 1.25 1.25 0.31 >5 0.16 
d >5 5.00 5.00 0.63 >5 0.31 
e >5 5.00 1.25 2.50 >5 1.25 
Cr >5 5.00 2.50 1.25 >5 0.16 
 
 
Flower C 
a A >5 
b 2.50 5.00 2.50 2.50 2.50 2.50 
c 1.25 1.25 0.16 0.08 1.25 0.08 
d 1.25 1.25 1.25 1.25 1.25 1.25 
e 1.25 1.25 1.25 1.25 0.63 1.25 
Cr >5 5.00 0.31 0.31 5.00 0.08 
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Stem Al fractions A >5  
 
 
 
 
 
Achi. 
milefolium L. 
 
 
Leaf C 
a >5 >5 >5 >5 >5 2.5 
b >5 >5 >5 >5 >5 2.5 
c >5 5.00 5.00 >5 >5 0.63 
d >5 >5 >5 >5 >5 2.50 
e >5 >5 >5 >5 >5 5.00 
Cr A >5  
 
Flower Cr 
a, b A >5  
c >5 5.00 2.50 2.50 >5 1.25 
d >5 5.00 5.00 5.00 >5 2.50 
e >5 >5 2.50 2.50 >5 1.25 
Cr >5 5.00 5.00 2.50 >5 0.63 
Stem Al fractions A >5  
 
 
 
 
 
Ascl. incarnata 
L. 
 
 
Leaf C 
a, b A >5  
c 5.00 2.50 2.50 2.50 5.00 2.50 
d A >5 
e 5.00 >5 >5 >5 2.50 5.00 
Cr 2.50 >5 5.00 5.00 2.50 2.50 
Root C a, b A >5 
c >5 >5 5.00 >5 >5 2.50 
d >5 >5 5.00 >5 >5 >5 
e >5 5 5.00 >5 >5 2.50 
Cr >5 >5 5.00 >5 >5 2.50 
Stem C a, b A >5 
c >5 >5 5.00 >5 >5 0.31 
d >5 >5 >5 >5 >5 1.25 
e >5 >5 >5 >5 >5 2.50 
Cr >5 >5 >5 >5 >5 2.50 
 
 
 
 
Arctium lappa 
Leaf E a, b, c, d A >5 
e >5 5.00 >5 >5 >5 5.00 
Cr >5 5.00 5.00 5.00 >5 5.00 
Flower D a >5 >5 >5 >5 >5 5.00 
b >5 >5 >5 >5 >5 2.50 
c >5 5.00 >5 2.50 >5 2.50 
d >5 5.00 >5 2.50 >5 0.63 
e >5 5.00 >5 5.00 >5 1.25 
Cr >5 5.00 5.00 2.50 >5 2.50 
Stem Al fractions A >5  
 
 
 
 
Arct. uva-ursi 
Leaf C a A >5  
b >5 >5 >5 5 >5 2.5 
c 5.00 1.25 0.63 0.63 5.00 0.63 
d 5.00 2.50 2.50 2.50 2.50 2.50 
e >5 5.00 5.00 >5 >5 5.00 
Cr >5 5.00 2.50 2.50 >5 1.25 
Stem Cr a, b A >5 
c 5.00 2.50 2.50 2.50 2.50 2.50 
d 5.00 5.00 2.50 5.00 2.50 2.50 
e >5 5.00 >5 >5 >5 5.00 
Cr 5.00 1.25 1.25 1.25 2.50 1.25 
 
 
 
 
Leaf Cr a, b A >5 
c >5 2.50 5.00 2.50 >5 2.50 
d >5 5.00 5.00 2.50 >5 2.50 
e >5 >5 5.00 5.00 >5 >5 
 
 
68 
Apoc. 
androsaemifoli
um L. 
Cr >5 5.00 1.25 1.25 2.50 1.25 
Stem C a A >5 
b >5 >5 5.00 5.00 >5 5.00 
c >5 2.50 5.00 2.50 >5 2.50 
d >5 >5 >5 >5 >5 5.00 
e A >5 
Cr >5 >5 5.00 5.00 >5 >5 
 
 
 
 
C. canadensis 
L. 
 
Leaf Cr 
a A >5 
b >5 5.00 1.25 2.50 5.00 2.50 
c 5.00 5.00 2.50 5.00 5.00 2.50 
d 5.00 5.00 5.00 5.00 5.00 2.50 
e >5 5.00 5.00 >5 >5 >5 
Cr >5 1.25 1.25 1.25 1.25 1.25 
Stem C a, b A >5 
c >5 >5 5.00 5.00 >5 2.50 
d >5 5.00 5.00 >5 >5 5.00 
e >5 2.50 2.50 >5 >5 5.00 
Cr >5 2.50 2.50 >5 >5 2.50 
 
E. 
angustifolium 
L. 
Leaf B a A >5 
b 5.00 5.00 5.00 5.00 5.00 2.50 
c >5 5.00 5.00 >5 >5 5.00 
d >5 >5 5.00 >5 >5 5.00 
e >5 >5 >5 >5 >5 5.00 
Cr 5.00 5.00 5.00 5.00 5.00 5.00 
 
 
 
 
 
 
 
G. squarrosa 
Leaf C a >5 >5 >5 >5 >5 2.50 
b >5 >5 >5 >5 >5 2.50 
c >5 2.50 0.63 0.63 >5 0.63 
d >5 5.00 2.50 2.50 >5 1.25 
e >5 5.00 5.00 >5 >5 5.00 
Cr >5 5.00 1.25 2.50 >5 1.25 
Flower Cr a, b A >5 
c >5 2.50 2.50 0.63 >5 2.50 
d >5 >5 5.00 >5 5.00 1.25 
e >5 >5 >5 >5 >5 5.00 
Cr >5 5.00 0.63 1.25 >5 0.31 
Stem C a A >5 
b >5 5.00 5.00 5.00 5.00 2.50 
c 2.50 5.00 0.63 5.00 0.63 0.31 
d >5 5.00 1.25 5.00 1.25 1.25 
e >5 5.00 5.00 >5 >5 5.00 
Cr >5 5.00 5.00 5.00 5.00 5.00 
 
H. odorata 
Leaf C a, b A >5 
c >5 2.50 5.00 1.25 5.00 0.63 
d >5 2.50 5.00 1.25 5.00 1.25 
e >5 2.50 >5 2.50 >5 2.50 
Cr >5 5.00 5.00 2.50 >5 1.25 
 
J. communis L. 
Leaf C a, b A >5 
c >5 >5 5.00 5.00 >5 5.00 
d >5 >5 >5 >5 >5 5.00 
e A >5 
Cr >5 >5 5.00 >5 >5 >5 
 
 
Leaf C a A >5 
b >5 2.50 >5 5.00 >5 >5 
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L. palustre 
c >5 2.50 2.50 2.50 >5 1.25 
d >5 5.00 5.00 2.50 >5 5.00 
e >5 >5 5.00 2.50 >5 2.50 
Cr >5 5.00 5.00 2.50 >5 1.25 
Stem C a, b A >5 
c >5 5.00 5.00 5.00 >5 2.50 
d >5 >5 5.00 5.00 >5 2.50 
e >5 >5 5.00 >5 >5 5.00 
Cr A >5  
 
L. annotinum 
Leaf B a A >5  
b >5 5.00 >5 2.50 >5 1.25 
c >5 >5 >5 >5 >5 5.00 
d, e       
Cr 2.50 5.00 2.50 2.50 2.50 5.00 
 
 
 
 
L. clavatum 
Leaf C a, b A >5 
c >5 >5 5.00 5.00 >5 1.25 
d >5 >5 2.50 5.00 >5 1.25 
e >5 >5 >5 >5 >5 5.00 
Cr >5 >5 >5 >5 >5 5.00 
Stem C a, b A >5 
c >5 5.00 5.00 2.50 >5 5.00 
d >5 5.00 5.00 5.00 >5 2.50 
e >5 >5 5.00 5.00 >5 5.00 
Cr >5 >5 >5 5.00 >5 5.00 
 
 
 
 
 
P. frigidus 
Leaf B a A >5 
b >5 1.25 2.50 2.50 1.25 0.63 
c >5 5.00 5.00 5.00 >5 1.25 
d >5 >5 >5 >5 >5 5.00 
e >5 >5 >5 >5 >5 5.00 
Cr >5 5.00 2.50 >5 >5 1.25 
Stem Cr a A >5 
b >5 >5 >5 >5 >5 5.00 
c >5 >5 >5 >5 >5 5.00 
d >5 >5 >5 >5 >5 5.00 
e A >5 
Cr >5 >5 >5 >5 >5 2.50 
 
 
 
 
P. vulgaris 
Leaf B a A >5 
b >5 5.00 5.00 1.25 5.00 0.31 
c >5 5.00 2.50 2.50 >5 1.25 
d >5 >5 >5 2.50 >5 2.50 
e >5 >5 >5 >5 >5 5.00 
Cr 5.00 5.00 5.00 5.00 5.00 2.50 
Flower C a, b A >5 
c >5 5.00 >5 5.00 >5 2.50 
d >5 >5 >5 5.00 >5 5.00 
e >5 5.00 >5 >5 >5 >5 
Cr A >5  
Stem Cr a, b, c A >5  
d >5 >5 >5 >5 >5 2.50 
e >5 >5 5.00 5.00 >5 >5 
Cr >5 >5 5.00 >5 >5 2.50 
 
 
Leaf C a, b A >5 
c >5 >5 >5 >5 >5 0.31 
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R. hirta L. 
d >5 >5 >5 >5 >5 1.25 
e >5 >5 >5 >5 >5 2.50 
Cr >5 >5 >5 >5 >5 1.25 
Stem D a A >5 
b >5 >5 >5 >5 >5 2.50 
c A >5 
d >5 >5 >5 >5 >5 1.25 
e >5 >5 5.00 >5 >5 5.00 
Cr >5 >5 5.00 >5 >5 2.50 
 
S. purpurea L. 
Leaf C a, b A >5 
c >5 5.00 2.50 2.50 5.00 1.25 
d >5 >5 5.00 >5 >5 2.50 
e >5 5.00 >5 2.50 >5 5.00 
Cr >5 5.00 >5 5.00 >5 2.50 
Root Al fractions A >5 
 
 
S. canadensis 
Leaf C a >5 >5 >5 >5 >5 5.00 
b >5 5.00 5.00 1.25 2.50 1.25 
c >5 5.00 >5 5.00 >5 0.16 
d 5.00 5.00 5.00 5.00 2.50 1.25 
e 5.00 >5 >5 >5 >5 5.00 
Cr >5 >5 5.00 2.50 >5 0.31 
Stem Al fractions A >5 
T. 
ceratophorum 
Stem Al fractions 
A >5 
 
 
 
 
X. strumarium 
L. 
Leaf C a 5 5.00 1.25 2.50 2.50 1.25 
b >5 2.50 >5 2.50 >5 1.25 
c >5 1.25 2.50 2.50 >5 0.63 
d >5 >5 5.00 5.00 >5 2.50 
e >5 5.00 2.50 2.50 5.00 5.00 
Cr >5 5.00 2.50 2.50 >5 2.50 
Stem C a >5 >5 >5 >5 >5 2.50 
b >5 >5 >5 >5 >5 2.50 
c >5 2.50 5.00 5.00 >5 2.50 
d >5 >5 >5 >5 >5 2.50 
e >5 >5 >5 >5 >5 2.50 
Cr >5 >5 >5 >5 >5 5.00 
Note: Al results are expressed as mean of duplicate measurements 
f Escherichia coli; g Aeromonas caviae; h Bacilus cereus; i Micrococcus luteus; j Mycobacterium avium subsp. 
avium; k Paenibacilus alvei 
a: Hex/ EtOAc 9:1; b: Hex/EtOAc 5:1; c: Hex/ EtOAc/ MeOH 0:1:0; d: EtOAc/MeOH 9:1; e: EtOAc/ MeOH 3:2; 
Cr: crude extract 
 A, B, C, D, E, Cr denotations on plant part indicate the fraction with the lowest observed MIC values for bacteria 
tested 
A >5 denotes minimum inhibitory concentration beyond the 5 mg/ml range  
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Table 4. MIC and MBC values for the crude extract of shortlisted medicinal plants 
Medicinal Plant Plant 
Part 
MIC (MBC) g (mg/ml) 
Gram Negative Gram Positive 
E. coli a A. caviae b B. cereus c M. luteus d M. avium e P. alvei f 
Anap. 
margaritacea 
Leaf  >5 (>5) 2.50 (2.50) 0.63 (1.25) 1.25 (1.25) >5 (>5) 0.16 (0.63) 
Flower  >5 (>5 5.00 (5.00) 0.31 (0.63) 0.31 (1.25) 5.00 (>5) 0.08 (0.16) 
Apoc. 
androsaemifolium  
Leaf  >5 (>5) >5 (>5) 1.25 (2.50) 1.25 (1.25) 2.50 (>5) 1.25 (1.25) 
Arct. uva-ursi Leaf  >5 (>5) >5 (>5) >5 (>5) 2.50 (2.50) >5 (>5) 1.25 (1.25) 
C. canadensis  Leaf  >5 (>5) 1.25 (1.25) 1.25 (2.50) 1.25 (1.25) 2.50 (>5) 1.25 (1.25) 
 
G. squarrosa  
Leaf  >5 (>5) 5.00 (5.00) 0.63 (1.25) 1.25 (1.25) >5 (>5) 0.31 (0.63) 
Flower  >5 (>5) 5.00 (5.00) 0.63 (0.63) 2.50 (2.50) >5 (>5) 1.25 (1.25) 
X strumarium  Leaf  >5 (>5) >5 (>50 >5 (>5) >5 (>5) >5 (>5) 2.50 (2.50) 
 
a Escherichia coli; b Aeromonas caviae; c Bacilus cereus; d Micrococcus luteus; e Mycobacterium avium subsp. 
avium; f Paenibacilus alvei 
g The value enclosed in the brackets corresponds to the MBC value  
 
 
 
 
Figure 1. Distribution of antibacterial activity in hole-plate diffusion and MIC assays. a. Statistical distribution of 
antibacterial activity by plant family in hole-plate diffusion assay. b. Statistical distribution of antibacterial activity 
by plant family in MIC assay.  
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Figure 2. Time kil plot of the short-listed northern Ontario 
medicinal plants against A. caviae (a), P. alvei (b), B. cereus (c) 
and M. luteus (d). Al the extracts were used at the MBC 
concentration.  
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Figure 3. Time kil plot of Anap. margaritacea flower against M. luteus (a), B. cereus (b), P. alvei (c) 
and A. caviae (d). The extract was used at concentrations equivalent to MIC, MBC, 2 X MBC, 3 X 
MBC and/ or ½ MBC values.  
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1. General Discussion  
 In this study, twenty-one northern Ontario medicinal plants were selected based on their 
traditional medicinal uses towards the treatment of oxidative stress related and infectious 
diseases. These plants were separated into leaf, flower, stem and root samples and extracted 
with ethanol. In total, forty-three plant extracts from twenty-one medicinal plants were 
analyzed for the assessment of their antioxidant and antibacterial activity. In the antioxidant 
assay, both ET (DPPH and ABTS assay) and HAT-based methods (ORAC assay) were 
utilized. The total phenolic content of medicinal plants was also determined. In the 
antibacterial assays, agar-difusion (Hole-plate diffusion) and broth dilution (MIC assay) 
methods were employed. Then, a few plants were shortlisted and analyzed for the 
determination of MBC value and time kil analyses. 
 In this investigation, plant extracts from Lycopodiaceae and Onagraceae family 
consistently display moderate to low antioxidant and antibacterial activity. The low 
antioxidant and antibacterial profiles of L. clavatum and L. annotinum from the 
Lycopodiaceae family has been reported in prior studies (Calderón et al. 2012; Konrath et al. 
2012). The low antioxidant activity may be atributed to presence of a thicker cuticle lined 
with waxy particles in these plants (Sun et al. 2005). This characteristic tends to reduce 
exposure to harmful near-infrared radiation (NIR) from sunlight via increased reflection at 
leaf surface (Orhan et al. 2007). A study by Slaton et al. (2001) demonstrated a high 
corelation (r2 = 0.93) between a thicker cuticle and increased NIR reflection. However, 
contrary to my data on E. angustifolium (Onagraceae), previous studies have reported 
moderately high antioxidant activity for this plant (Li et al. 2012; Shikov et al. 2006). 
Though low antibacterial activity for E. angustifolium is consistent with prior studies 
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(Borchardt et al. 2008 a; Borchardt et al. 2008 b). For instance, Borchardt et al. (2008) 
demonstrated inhibition diameters for E. angustifolium in a similar range (7- 20 mm) to those 
observed in present study (9 - 22 mm). Interestingly, consistent with a study by Miceli et al. 
(2009) on J. communis from Turkey, the J. communis leaf extract (Cupressaceae) displayed 
antibacterial activity, albeit low, only against Gram-positive bacteria. This activity has been 
atributed to the presence of flavonoids, particularly apigenen (Miceli et al. 2009). The leaf 
extract of J. communis also displayed moderate radical scavenging capability, which has been 
atributed to the presence of quercetin-hexoside and isoscutelarein-8-O-hexoside flavonoids 
(Miceli et al. 2009).  
 Plant extracts from the Asteraceae family display moderate to high antibacterial activity, 
but low antioxidant capacities. Similar observations have been reported in prior studies. A 
study by Juteau et al. (2002) on the essential oil of Artemisia annua L. (Asteraceae) reported 
a MIC value of 0.05 mg/ml against E. coli, however, a relatively weak antioxidant activity. A 
study by Mothana et al. (2011) on Yemeni medicinal plants (Carthamus tinctorius L., 
Centaurea pseudosinaica Czerep.) of Asteraceae family, reported low antioxidant activity 
(EC50: 100 - 540 μg/ ml) and a moderately high antibacterial activity (ZOI: 9-14 mm) against 
five Gram-positive and Gram-negative bacteria. However, there were exceptions to this 
trend. In the antibacterial studies, ten and four plant extracts from this family exhibited no 
antibacterial activity in the hole-plate diffusion and MIC assays, respectively. Extracts from 
A. margaritacea leaf and flower display exceptional antibacterial and moderately high 
antioxidant activity. Also, contrary to my data, a study by Candan et al. (2003) on A. 
milefolium (Asteraceae) from Turkey reported a relatively high antioxidant activity for this 
plant. In the present investigation, A. milefolium displays a low phenolic content (below 100 
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mg GAE/ 10 gdw) and performs poorly in ABTS and DPPH assay (activity below 60 μM TE/ 
gdw). However, it exhibits an unexpectedly high activity in ORAC assay in the range of 230 
- 355 μM TE/ gdw for stem, leaf and flower extracts. Overal, in agreement with Candan et 
al. (2003), A. milefolium displays moderately low ZOI diameters (between 6 - 16 mm) and 
MIC values (majority over 1.25 mg/ml). 
1.1. Most Promising Medicinal Plants 
 The leaf, stem and/ or flower extracts of Xanthium strumarium, Anaphalis margaritacea, 
Solidago canadensis and Grindelia squarrosa from the Asteraceae family exhibit the largest 
ZOI and lowest MIC values. Decoctions of these plants are used in the aboriginal 
community to aleviate infectious diseases. For instance, a paste extracted from the leaf 
tissues of Anaphalis margaritacea is routinely applied on wounds, rashes or cuts to prevent 
infections. Previous studies on this plant have isolated multiple hydroxylactones responsible 
for antimicrobial activity (Ahmed et al. 2004). Xanthium strumarium, a common weed, has 
also been used for the treatment of tuberculosis, diarhea, malaria, constipation, bacterial and 
fungal infections (Anjoo & Ajay 2010). Xanthol, xanthinin and xanthanolide sesquiterpenes 
have been identified as the active metabolites (Jawad et al. 1988; Sato et al. 1997). Solidago 
canadensis is also a wel-researched plant and the antimicrobial activity has been atributed to 
the presence of several clerodane-type diterpenes (Kruszewska et al. 2004; Lu et al. 1993). 
However, research on Grindelia squarrosa was found to be vastly lacking. Previous study on 
a separate species, Grindelia tarapacana, has isolated manoyloxide type diterpenoids 
exhibiting pronounced antibacterial and anti-tuberculosis activity (Zhou et al. 1995). Some 
of the diterpenoids isolated displayed a more potent anti-tuberculosis activity (MIC = 32 
μg/ml) than the anti-tuberculosis agent pyrazinamide (40 μg/ml). Therefore, a biochemical 
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analysis on Grindelia squarrosa, a North American species of gumweed, could yield 
promising new antibacterial compounds and future studies should be tailored towards this 
aspect. 
 The extracts from Cornaceae, Lamiaceae and Ericaceae family display highest 
antioxidant activity. From these plant families, the leaf extracts of Arctostaphylos uva-ursi, 
P. vulgaris, L. palustre, and C. canadensis display the most promising activity. P. vulgaris 
(also known as heal al) is wel known for its antioxidant, anti-inflammatory, antibacterial 
and antidiarheal activity (Lee et al. 2008; Liu & Ng 2000; Psotova et al. 2006; Skotová et 
al. 2004). The crude extract of heal-al consists of rosmarinic acid (Psotová et al. 2003), 
triterpenoids, flavonoids, anthocyanins, oleanoic acid, betulinic acid, cafeic acid, tannins and 
anionic polysaccharides (Cai et al. 2004; Psotová et al. 2005). Rosmarinic acid is a known 
antibacterial, antiviral, antioxidant and anti-inflammatory agent (Petersen & Simmonds 
2003). Oleanoic, caffeic, and betulinic acid are also wel known antioxidant agents. Previous 
research on L. palustre (Labrador tea) has shown antioxidant, anti-inflammatory, 
antimicrobial, and anticancer activity (Dufour et al. 2007). HPLC and GC-MS analysis of the 
Labrador tea aerial parts has isolated monoterpenes, sesquiterpenes, esculin, quercetin 
glycosides, acetylated flavonoids, glucoside fraxin and dihydric alcohols (Chosson et al. 
1998; Fylaktakidou et al. 2004; Nam 2006). Arctostaphylos uva-ursi is also wel-researched 
plants and its bioactivity has been atributed to presence of arbutin (Jahodár et al. 1985). 
Overal, C. canadensis (Dogwood) exhibits the highest antioxidant activity in SET-assays 
and the total phenolic content; however, it ranked relatively poorly in the ORAC assay. This 
activity could be atributed to a poor competition for peroxy radical, or a lack of solubilizing 
agents applied in ORAC method that could have confiscated the activity of lipophilic 
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phenolic groups (Cheng et al. 2006). Overal, through a research survey, no isolation or in 
vivo study on the extracts of C. canadensis was identified in literature. This presents a unique 
and promising incentive for future research on C. canadensis.  
 
2. Future Directions 
 An antioxidant compound is a substance that significantly reduces the oxidation of an 
oxidizable substrate at low concentrations. The curent study identifies the antioxidant 
activity of medicinal plants through DPPH, ABTS, ORAC and total phenolic content assays. 
However many other in vitro and in vivo methods exist in literature that can elucidate the 
important characteristics of compounds from crude plant extracts. 
 Oxidative stress can cause lipid peroxidation, especialy in polyunsaturated faty acids 
(PUFA), since presence of a double bond weakens the C-H bond on the adjacent carbon 
atoms, facilitating H+ removal (Niki 2010). The oxidation of PUFA or other lipids can have 
detrimental efects in cels as the membrane characteristics and function of associated 
receptors or proteins may be impaired. The oxidized lipids can further degrade to unsaturated 
aldehydes (Repine et al. 1997), which can also alter cel function by inhibiting antiproteases 
and cyclooxygenases, activating latent procolagenese, and reacting with arachidonic acid 
(Niki 2010). Measurement of the products of lipid peroxidation (e.g. Malondialdehyde and 
F2- isoprostanes) are routinely used to determine antioxidant activity in vitro and in vivo. 
Thiobarbituric acid-reactive substance (TBARS) assay is used to quantify antioxidant 
capacity of extracts based on their ability to reduce the formation of malondialdehyde - 
thiobarbituric acid (MDA-TBA) adduct. However, this assay lacks sensitivity and specificity 
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due to side reactions of TBA with hemoglobin and rapid metabolism of MDA, which 
represents only 1% of lipid peroxides (Pincemail et al. 1996). Templar et al. (1999) reported 
higher sensitivity in TBARS assay by incorporating HPLC to separate MDA-TBA from 
interfering compounds, and subsequent detection at 532 nm. However, the most reliable 
method to quantify oxidative stress by lipid peroxidation is through measurement of F2-
isoprostanes (Liu et al. 2009). F2-isoprostane biomarkers are structuraly stable, produced in 
vivo, and are present in relatively high concentrations (Montuschi et al. 2007). Increased 
plasma concentration of F2-isoprostane levels has been reported for smokers (Dietrich et al. 
2002), patients sufering from oxidative stress during acute hyperglycemia type 2 diabetes, 
(Sampson et al. 2002) and breast cancer (Stol 2002). Through support from the National 
Institute of health (NIH), Milne et al. (2007) published an excelent method in Nature 
Protocols to quantify F2-isoprostanes as the most reliable biomarker of oxidative stress in 
vitro or in vivo. Their protocol utilizes GC-MS to determine accurate levels of F2-
isoprostanes in 12 - 16 urine or blood samples in 6 - 8 hours.  
 Studies also measure oxidative damage on DNA by quantifying urinary excretion of the 
DNA-repair product, 8-hydroxydeoxyguanosine (8-ohdG), through HPLC (Svoboda & Kasai 
2004). However, this method is rarely implemented due to higher cost and time alotment. In 
my perspective, future antioxidant studies should be tailored towards determination of 
TBARS in vitro for the most promising medicinal plants and isolation of the potentialy 
bioactive metabolites. However, HPLC-MS, GC-MS or LC-MS can be performed directly 
on the crude extracts to determine the major constituents, in reference to standard phenolic 
compounds. At the most advanced stage, the bioactive components can be assayed for their 
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therapeutic and lethal concentration (mice studies) and effect on F2-isoprostane concentration 
in vivo as a measure of antioxidant action in a biological system.  
 The antimicrobial activity of medicinal plants was evaluated through hole-plate difusion 
and minimum inhibitory concentration (MIC) assays. The future steps could be to assess the 
antibacterial activity of medicinal plants on clinical isolates, particularly Pseudomonas 
species, methicilin resistant Staphylococcus aureus (MRSA), mycobacterium tuberculosis, 
Aeromonas caviae (Clinical isolate) and Aeromonas hydrophilia due to their high 
pathogenicity and/ or multiple drug resistance. Also, the bacteriostatic and/ or bactericidal 
antibacterial action of bioactive metabolites in crude extract must be determined. Further, the 
in vivo studies on treatment of bacteremia in mice or pigs, prevention of vegetable or food 
decay (e.g. Buternut squash) or mouth borne diseases in mice are also important to conduct. 
Overal, isolation strategies should be performed on the most promising medicinal plants to 
determine the architectures of bioactive metabolites responsible for the antibacterial activity. 
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APPENDIX A 
Calibration Curves for Antioxidant Assays 
 
 
 
 
  
 
 
  
 
 
Figure 1.  Calibration curves for ORAC, DPPH, ABTS, and total phenolic content assays. 
a. DPPH calibration curve. b. ABTS Calibration curve. c. Calibration curve for 
total phenolic content assay. d. Calibration curve for ORAC assay.   
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Appendix B 
Characteristics of Crude and LC Fractions  
 
Table 1. Mass of 43 crude extracts from 21 northern Ontario medicinal plants  
Medicinal Plant Plant 
Part 
Crude 
Extract mass 
(mg / gdw) a 
Achi. milefolium L. Leaf  82.8 
Flower  64.0 
Stem  45.4 
Anap. margaritacea Leaf 194.4 
Flower 162.3 
Stem  62.6 
Apoc. androsaemifolium L. Leaf 197.9 
Stem  61.1 
Arct. uva-ursi Leaf 152.7 
Stem 105.8 
Arctium lappa Leaf 167.9 
Flower 135.6 
Stem 103.6 
Ascl. incarnate L. Leaf 166.5 
Root 177.8 
Stem 219.5 
C. canadensis L. Leaf 115.7 
Stem  79.4 
E. angustifolium L. Leaf 162.0 
G. squarrosa Leaf 157.5 
Flower 144.5 
Stem  88.0 
H. odorata Leaf  86.5 
J. communis L Leaf 108.9 
L. palustre Leaf 327.6 
Stem 145.2 
L. annotinum Leaf 100.0 
L. clavatum Leaf 172.8 
Stem  98.3 
P. frigidus Leaf 185.2 
Stem 115.3 
P. vulgaris Leaf 131.6 
Flower 115.2 
Stem  80.0 
R. hirta L Leaf 118.9 
Stem  68.6 
S. purpurea L. Leaf 348.6 
Root 112.4 
S. canadensis Leaf 130.8 
Stem  119.7 
T. ceratophorum Stem 118.6 
X. strumarium L. Leaf 110.0 
Stem   64.7 
a The extract mass entails mg of crude extract weight / gram of dried plant weight 
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Table 2. Physical characteristics of the LC fractions and their respective recovery 
Medicinal Plant Plant 
Part 
Fraction mass and Physical Characteristics** % 
Yield f 
F1a F2b F3c F4d F5e 
Achi. milefolium 
L. 
Leaf Orange-
yelowish 
oil (13.4 
mg) 
Light 
green oil 
(13.7 mg) 
Dark green 
oil (20.5 
mg) 
Light green 
precipitate 
(15.4 mg) 
Brownish 
colored 
precipitate 
(25.7 mg) 
80.2 
Flower Clear oil 
(13.8 mg) 
Light 
green oil 
(14.7 mg) 
Dark green 
oil (21.7 
mg) 
Greenish 
orange 
precipitate/ 
solid (19.7 
mg) 
Orange-
brownish 
solid/ 
precipitate 
(37.8 mg) 
72.4 
Stem Yelowish 
paste (14.3 
mg) 
Yelowish 
paste (15.1 
mg) 
Dark green 
paste (20.0 
mg) 
Yelowish 
green solid 
(13.1 mg) 
Yelowish 
green 
precipitate 
(69.0 mg) 
94.6 
Anap. 
margaritacea 
Leaf Yelowish 
oil (36.7 
mg) 
Yelowish 
oil (26 
mg) 
Greenish 
solid (77.2 
mg) 
Light green 
solid (31.5 
mg) 
Dark reddish 
orange solid 
(177.8 mg) 
89 
Flower Yelowish 
oil (26.7 
mg) 
Yelowish 
oil (49.8 
mg) 
Greenish 
solid (52.5 
mg) 
Yelowish-
green solid 
(59.8 mg) 
Dark reddish 
orange solid 
(103.4 mg) 
83.5 
Stem Yelow oil 
(16.4 mg) 
Yelow 
green oil 
(19.2 mg) 
Green 
paste (18.1 
mg) 
Yelowish 
green 
precipitate 
(27.3 mg) 
Greenish 
precipitate 
(30.0 mg) 
84.7 
Apoc. 
androsaemifolium 
L. 
Leaf Yelowish 
oil (15.8 
mg) 
Greenish 
yelow 
paste (14.6 
mg) 
Dark green 
oil/ paste 
(19.9 mg) 
Dark green 
precipitate 
(21.0 mg) 
Dark green 
precipitate 
(33.8 mg) 
86.8 
Stem Off white 
oil paste 
(14.3 mg) 
Off white 
oil paste 
(19.6 mg) 
Dark green 
oil (22.3 
mg) 
Light green 
solid (14.9 
mg) 
Off whitish-
green 
precipitate or 
crystal--its 
kind of flufy 
(84.2 mg) 
80.5 
Arct. uva-ursi Leaf Greenish 
yelow 
(17.5 mg) 
Light 
green noil 
(19.5 mg) 
Off white 
greenish 
paste (24.9 
mg) 
Yelowish 
but slight 
green solid 
(29.2 mg) 
Yelowish 
green 
precipitate 
(37.95 mg) 
79.1 
Stem Off white 
oil/ paste 
(20.4 mg) 
Clear (18.7 
mg) 
Light 
green paste 
(31.8 mg) 
Light green 
solid (52.8 
mg) 
Yelowish 
precipitate 
(59.0 mg) 
76.6 
Arctium lappa Leaf Yelowish 
dark oil 
(16.2 mg) 
Light 
yelow oil 
(14.4 mg) 
Dark 
green-
brownish 
oil (19.5 
mg) 
Light green 
oil/ paste 
(15.5 mg) 
Dark 
brownish oil/ 
paste (45.8 
mg) 
68 
Flower Colorless 
oil (16.9 
mg) 
Colorless 
oil/ paste 
(19.7 mg) 
Dark 
greenish 
precipitate/ 
paste (19.6 
mg) 
Light green 
paste (14.1 
mg) 
Dark green-
brownish 
crystal/ 
precipitate 
(42.9 mg) 
61 
 85 
Stem Off white 
wax (12 
mg) 
Off white 
waxy oil 
(13.4 mg) 
Dark green 
paste (25.7 
mg) 
Light green 
solid (20.5 
mg) 
Light 
greenish 
precipitate 
(43.0 mg) 
97 
Ascl. incarnate L. Leaf Yelowish 
oil (14.3 
mg) 
Yelowish 
oil (14.4 
mg) 
Green oil 
(19.9 mg) 
Green oil 
(13.4 mg) 
Green 
precipitate 
(57.3 mg) 
90 
Root Off white 
paste (13.0 
mg) 
Off white 
paste (13.8 
mg) 
Light 
green paste 
(16.9 mg) 
Light green 
paste (17.4 
mg) 
Very fluffy, 
light green/ 
white and 
seems to have 
crystalized 
(144.6 mg) 
93 
Stem Off white 
paste (12.3 
mg) 
Off whitish 
paste (20.6 
g) 
Dark green 
precipitate 
(22.5 mg) 
Light green 
solid (17.6 
mg) 
Yelowish 
green crystal 
foaming 
(263.7 mg) 
95 
C. canadensis L. Leaf Colorless 
oil (15.6 
mg) 
Yelowish 
oil (32.0 
mg) 
Dark green 
paste (40.0 
mg) 
Light green 
precipitate 
(30.0 mg) 
Yelowish 
green solid 
(105.0 mg) 
85.6 
Stem Yelowish 
oil (22.0 
mg) 
Light 
green oil 
(29.0 mg) 
Green 
yelowish 
paste (33.0 
mg) 
Off white 
greenish 
precipitate 
(53.0 mg) 
Yelowish 
orange solid 
(157.8 mg) 
93.2 
E. angustifolium 
L. 
Leaf Yelowish 
oil (13.0 
mg) 
Greenish 
oil (21.7 
mg) 
Yelowish 
oil (25.0 
mg) 
Yelowish 
oil (17.4 mg) 
Orange 
precipitate 
(25.0 mg) 
79 
G. squarrosa Leaf Yelowish 
oil (12.0 
mg) 
Yelowish 
oil (17.6 
mg) 
Dark green 
paste (18.9 
mg) 
Yelowish 
green paste 
(23.1 mg) 
Reddish 
precipitate 
(29.1 mg) 
80 
Flower Yelowish 
oil (12.4 
mg) 
Yelowish 
oil (17.7 
mg) 
Dark green 
paste (17.5 
mg) 
Yelowish 
green paste 
(19.5 mg) 
Reddish 
precipitate 
(27.0 mg) 
89.2 
Stem Off white 
oil (12.3 
mg) 
Light 
yelowish 
oil (17.6 
mg) 
Light 
green 
precipitate 
(23.6 mg) 
Light green 
paste (14.4 
mg) 
Dark green-
brownish 
crystal (84.0 
mg) 
90 
H. odorata Leaf Dark 
yelowish 
oil (15.0 
mg) 
Yelowish 
oil (14.9 
mg) 
Dark green 
oil/ paste 
(24.4 mg) 
Dark green 
precipitate 
(15.1 mg) 
Dark 
brownish-
orange red 
crystal 
formed (97.2 
mg) 
76 
J. communis L Leaf Nothing 
eluted 
Off white 
paste (12.7 
mg) 
Dark green 
solid (18.6 
mg) 
Dark green 
solid (14.6 
mg) 
Brownish 
precipitate 
(40.1 mg) 
97 
L. palustre Leaf Yelowish 
oil (15.2 
mg) 
Light 
green oil/ 
paste (17.8 
mg) 
Dark green 
oil (78.9 
mg) 
Light green 
solid (76.6 
mg) 
Brownish 
dark crystals 
formed 
(143.9 mg) 
82 
Stem Colorless 
oil (12.3 
mg) 
Light 
yelowish-
green oil 
(17.6 mg) 
Light 
green 
precipitate 
(23.6 mg) 
Light green 
paste (14.4 
mg) 
Dark green-
brownish 
crystal (84.0 
mg) 
78 
L. annotinum Leaf Yelowish Greenish Greenish Yelowish- Reddish 82.2 
 
 
86 
oil (22.6 
mg) 
yelow oil 
(27.5 mg) 
solid (32.0 
mg) 
green solid 
(14.3 mg) 
orange solid 
(125.6 mg) 
L. clavatum Leaf Whitish 
paste (12.9 
mg) 
Yelowish 
paste (16.8 
mg) 
Green 
paste (13.3 
mg) 
Light green 
precipitate/ 
solid (17.2 
mg) 
Orange-
greenish solid 
(37.1 mg) 
62.3 
Stem White oil/ 
paste (14.1 
mg) 
Off white 
oil/ paste 
(17.1 mg) 
Dark green 
precipitate 
(24.0 mg) 
Off white-
greenish 
precipitate 
(17.8 mg) 
Orange oily 
paste (46.5 
mg) 
82.6 
P. frigidus Leaf Colorless 
oil/ paste 
(14.7 mg) 
Yelowish 
green paste 
(17.2 mg) 
Green oil/ 
paste (17.6 
mg) 
Light 
greenish 
yelow 
precipitate 
(23.8 mg) 
Colorless 
precipitate 
(22.2 mg) 
81.6 
Stem Yelowish 
green paste 
(16.4 mg) 
Yelowish 
green paste 
(13.0 mg) 
Light 
green paste 
(16.7 mg) 
Off whitish 
solid (15.0 
mg) 
Light green 
solid (86.0 
mg) 
58 
P. vulgaris Leaf Yelowish 
oil (25.9 
mg) 
Greenish 
oil (26.3 
mg) 
Green very 
oily (31.2 
mg) 
Green 
precipitate 
forming 
(132.2 mg) 
Orange 
crystal (137.2 
mg) 
82.1 
Flower Colorless 
oil (12.4 
mg) 
Yelowish 
oil/ paste 
(20.0 mg) 
Dark green 
precipitate 
(29.0 mg) 
Light green 
solid / 
powder 
(17.8 mg) 
Brownish 
crystal (80.4 
mg) 
76 
Stem Off-white 
paste (13.7 
mg) 
Yelowish-
green paste 
(12.0 mg) 
Light 
greenish 
white 
powdery 
solid (20.4 
mg) 
Whitish 
Green 
precipitate-
powdery 
material 
(30.0 mg) 
Dark reddish 
brown solid/ 
paste (47.3 
mg) 
97 
R. hirta L Leaf Off white 
wax (7 mg) 
Yelowish 
oil (15.3 
mg) 
Dark green 
paste (24.7 
mg) 
Light green 
precipitate 
(13.4 mg) 
Light green 
solid (30.7 
mg) 
93 
Stem Yelowish 
green paste 
(16.7 mg) 
Colorless 
paste (16.6 
mg) 
Dark 
Green 
precipitate 
(24.3 mg) 
Light green 
solid (14.3 
mg) 
Light 
greenish / 
yelow solid 
(37.1 mg) 
88 
S. purpurea L. Leaf Yelowish 
oil (22.0 
mg) 
Yelowish 
oil (24.0 
mg) 
Dark green 
paste (32.5 
mg) 
Light green 
solid (27.0 
mg) 
Yelowish 
crystalization 
(102.0 mg) 
92.6 
Root Colorless 
paste (20.0 
mg) 
Colorless 
paste (20.0 
mg) 
Yelowish 
green solid 
(44.1 mg) 
Whitish 
solid at sides 
but green in 
middle (48.5 
mg) 
Orange solid, 
but also 
seems like a 
paste (97 mg) 
90 
S. canadensis Leaf Yelowish 
oil (15.0 
mg) 
Whitish 
yelow oil 
(13.4 mg) 
A green 
paste (87.0 
mg) 
Light green 
solid (30.0 
mg) 
Orangish red 
precipitate 
(91.2 mg) 
84.6 
Stem  Off whitish 
paste/ oil 
(15.2 mg) 
Off whitish 
paste/ oil 
(14.4 mg) 
Green 
paste (17.3 
mg) 
Light green 
precipitate 
(13.4 mg) 
Dark green 
waxy material 
(32.5 mg) 
83 
T. ceratophorum Stem Off-white 
paste (12.3 
Yelowish-
green paste 
Light 
greenish 
Whitish 
Green 
Dark reddish 
brown solid/ 
97 
 87 
mg) (12.0 mg) white 
powdery 
solid (20.4 
mg) 
precipitate-
powdery 
material (15 
mg) 
paste (27.3 
mg) 
X. strumarium L. Leaf Yelowish 
oil (15.8 
mg) 
Whitish 
yelow oil 
(15 mg) 
A green 
paste (19.7 
mg) 
Light green 
solid (24.0 
mg) 
Greenish 
precipitate 
(82.0 mg) 
77 
Stem  Waxy 
substance, 
of white 
(14.0 mg) 
Waxy 
substance, 
of white 
(14.4 mg) 
Light 
green solid 
(15.4 mg) 
Light green 
solid (12.9 
mg) 
Light green 
precipitate 
(31.6 mg) 
88.9 
a Hex/ EtOAc 9:1; b Hex/EtOAc 5:1; c Hex/ EtOAc/ MeOH 0:1:0; d EtOAc/MeOH 9:1; e EtOAc/ MeOH 3:2 
f % yield = [(mass F1 + mass F2 + mass F3 + mass F4 + mass F5) / (Mass crude extract added in LC)] * 100% **The characteristics and mass of fractions was determined after they were dried under high vacuum for 24 hours. 
The fractions were sealed with parafilm and stored at -80 oC until required for analysis.  
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